{"doc_id": 0, "doc": {"person_id": 115967545, "visit_occurrence_id": 168111161, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2020-10-28 00:00:00", "visit_end_datetime": "2020-10-28 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 91, "patient_first_visit_date": "2017-08-08 00:00:00", "patient_last_visit_date": "2021-12-21 10:38:54", "end_obs_date": "2021-10-28", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 43, "cumulated_visit_num": 43, "cumulated_approximate_token_count": 10330, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-08 00:00:00, ended at 2017-08-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-08 13:48:42, ended at 2017-08-08 15:19:30\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Disorder of kidney and/or ureter\n- Sleep apnea\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (40 mg total) by mouth daily\n- atorvastatin 80 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth daily\n- rivaroxaban 20 MG Oral Tablet, started on 2017-05-14, presumably until 2017-05-14, with intended 1 refill(s). Instructions: every day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-08 15:32:00, ended at 2017-08-08 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.50 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 10:56:00, ended at 2017-09-25 13:48:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-09-25, presumably until 2017-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 13:49:00, ended at 2017-09-25 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 08:01:39, ended at 2017-11-12 08:54:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.32\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic fibrosis\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 12:31:12, ended at 2017-11-12 14:23:32\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Urogenital finding\n- Primary diagnosis: Hydronephrosis\n- Acute renal failure syndrome\n- Chronic kidney disease stage 3\n- Urinary tract obstruction\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-15 00:00:00, ended at 2017-11-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-27 00:00:00, ended at 2017-11-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Acute non-ST segment elevation myocardial infarction\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-12 07:14:00, ended at 2017-12-12 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.08 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 208 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-12 07:56:19, ended at 2017-12-12 09:36:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thromboembolism of vein\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 07:20:00, ended at 2017-12-28 07:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.8 (percent)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 09:30:00, ended at 2017-12-28 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 67 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, started on 2018-01-10, presumably until 2018-02-06, with intended 0 refill(s). Instructions: One syringe subcu 01/15/2018 q 12 hours.  Last syringe 01/16/2018 in am.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 09:57:45, ended at 2018-01-10 12:06:21\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-10 12:13:00, ended at 2018-01-10 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.39 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.1 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 164 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney and/or ureter\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 13:00:12, ended at 2018-01-10 14:06:34\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; renal procedures, including upper one-third of ureter, or donor nephrectomy\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hydronephrosis\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- cefazolin 1000 MG Injection, started on 2018-01-17, presumably until 2018-01-17\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- ketamine 100 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- iothalamic acid, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- iothalamate, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 06:01:00, ended at 2018-01-20 13:20:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.05 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -2.9 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 178.0 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Carbon dioxide [Partial pressure] in Arterial blood: 38.5 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 145 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Ultrasonic guidance, intraoperative\n- Resection of Right Kidney, Percutaneous Endoscopic Approach\n- Excision of Right Kidney, Percutaneous Endoscopic Approach, Diagnostic\n- Laparoscopy, surgical; pyeloplasty\n- Cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service\n- Robotic Assisted Procedure of Trunk Region, Percutaneous Endoscopic Approach\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Laparoscopy, surgical; nephrectomy, including partial ureterectomy\n\n### Condition\n- Aortocoronary bypass graft present\n- Coagulation factor deficiency syndrome\n- Hydronephrosis\n- Anesthesia of skin\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Uncomplicated asthma\n- Obstructive sleep apnea syndrome\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic kidney disease stage 3\n- Old myocardial infarction\n- Chronic kidney disease due to hypertension\n- Illness\n- Primary malignant neoplasm of kidney\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2018-01-17, presumably until 2018-01-20\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-01-20, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-01-17, presumably until 2018-01-18\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-19\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-02-03 00:00:00, ended at 2018-02-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of urinary system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-06 00:00:00, ended at 2018-02-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cellulitis of abdominal wall\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-02-06, presumably until 2018-02-13, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 09:57:06, ended at 2018-02-06 12:47:03\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney, NOS\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 13:02:00, ended at 2018-02-06 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.26 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.34 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cellulitis of abdominal wall\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 14:24:01, ended at 2018-02-06 14:57:17\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:13:00, ended at 2018-05-08 07:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:14:00, ended at 2018-05-08 10:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 10:14:00, ended at 2018-05-08 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-08 10:31:15, ended at 2018-05-08 12:28:13\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:05:00, ended at 2018-12-26 07:20:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.83 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.3 (percent)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Absent kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-26 09:41:30, ended at 2018-12-26 10:32:44\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-30 00:00:00, ended at 2019-09-30 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-25 06:59:00, ended at 2019-12-25 06:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Non-toxic multinodular goiter\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-08 00:00:00, ended at 2017-08-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-08 13:48:42, ended at 2017-08-08 15:19:30\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Disorder of kidney and/or ureter\n- Sleep apnea\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (40 mg total) by mouth daily\n- atorvastatin 80 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth daily\n- rivaroxaban 20 MG Oral Tablet, started on 2017-05-14, presumably until 2017-05-14, with intended 1 refill(s). Instructions: every day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-08 15:32:00, ended at 2017-08-08 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.50 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 10:56:00, ended at 2017-09-25 13:48:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-09-25, presumably until 2017-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 13:49:00, ended at 2017-09-25 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 08:01:39, ended at 2017-11-12 08:54:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.32\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic fibrosis\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 12:31:12, ended at 2017-11-12 14:23:32\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Urogenital finding\n- Primary diagnosis: Hydronephrosis\n- Acute renal failure syndrome\n- Chronic kidney disease stage 3\n- Urinary tract obstruction\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-15 00:00:00, ended at 2017-11-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-27 00:00:00, ended at 2017-11-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Acute non-ST segment elevation myocardial infarction\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-12 07:14:00, ended at 2017-12-12 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.08 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 208 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-12 07:56:19, ended at 2017-12-12 09:36:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thromboembolism of vein\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 07:20:00, ended at 2017-12-28 07:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.8 (percent)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 09:30:00, ended at 2017-12-28 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 67 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, started on 2018-01-10, presumably until 2018-02-06, with intended 0 refill(s). Instructions: One syringe subcu 01/15/2018 q 12 hours.  Last syringe 01/16/2018 in am.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 09:57:45, ended at 2018-01-10 12:06:21\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-10 12:13:00, ended at 2018-01-10 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.39 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.1 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 164 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney and/or ureter\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 13:00:12, ended at 2018-01-10 14:06:34\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; renal procedures, including upper one-third of ureter, or donor nephrectomy\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hydronephrosis\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- cefazolin 1000 MG Injection, started on 2018-01-17, presumably until 2018-01-17\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- ketamine 100 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- iothalamic acid, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- iothalamate, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 06:01:00, ended at 2018-01-20 13:20:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.05 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -2.9 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 178.0 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Carbon dioxide [Partial pressure] in Arterial blood: 38.5 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 145 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Ultrasonic guidance, intraoperative\n- Resection of Right Kidney, Percutaneous Endoscopic Approach\n- Excision of Right Kidney, Percutaneous Endoscopic Approach, Diagnostic\n- Laparoscopy, surgical; pyeloplasty\n- Cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service\n- Robotic Assisted Procedure of Trunk Region, Percutaneous Endoscopic Approach\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Laparoscopy, surgical; nephrectomy, including partial ureterectomy\n\n### Condition\n- Aortocoronary bypass graft present\n- Coagulation factor deficiency syndrome\n- Hydronephrosis\n- Anesthesia of skin\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Uncomplicated asthma\n- Obstructive sleep apnea syndrome\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic kidney disease stage 3\n- Old myocardial infarction\n- Chronic kidney disease due to hypertension\n- Illness\n- Primary malignant neoplasm of kidney\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2018-01-17, presumably until 2018-01-20\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-01-20, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-01-17, presumably until 2018-01-18\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-19\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-02-03 00:00:00, ended at 2018-02-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of urinary system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-06 00:00:00, ended at 2018-02-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cellulitis of abdominal wall\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-02-06, presumably until 2018-02-13, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 09:57:06, ended at 2018-02-06 12:47:03\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney, NOS\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 13:02:00, ended at 2018-02-06 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.26 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.34 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cellulitis of abdominal wall\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 14:24:01, ended at 2018-02-06 14:57:17\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:13:00, ended at 2018-05-08 07:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:14:00, ended at 2018-05-08 10:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 10:14:00, ended at 2018-05-08 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-08 10:31:15, ended at 2018-05-08 12:28:13\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:05:00, ended at 2018-12-26 07:20:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.83 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.3 (percent)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Absent kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-26 09:41:30, ended at 2018-12-26 10:32:44\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-30 00:00:00, ended at 2019-09-30 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-25 06:59:00, ended at 2019-12-25 06:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Non-toxic multinodular goiter\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c7f2e67e959f3f68ead2d889c2f719e43217c79c5dd92f832286f7421c6d6d8e", "prompt_hash": "726897fb97b7f089c63446832137ec338b3ca9b0240e5a3eb6c56ec9b97ef8a9", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967648, "visit_occurrence_id": 180405753, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2021-06-06 00:00:00", "visit_end_datetime": "2021-06-06 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-06 00:00:00, ended at 2021-06-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2019-12-21 00:00:00", "patient_last_visit_date": "2023-01-16 00:00:00", "end_obs_date": "2022-06-06", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 83, "cumulated_visit_num": 83, "cumulated_approximate_token_count": 13523, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 11:43:13, ended at 2019-12-21 13:57:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2019-03-04, presumably until 2020-12-16, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:00:00, ended at 2019-12-21 14:42:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Persistent atrial fibrillation\n- Chronic atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:43:00, ended at 2019-12-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-28 00:00:00, ended at 2020-01-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-29 07:00:00, ended at 2020-01-29 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Ventricular tachycardia\n- Atrial flutter\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily Start on 05/10 and continue until prescription is completed.\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (1 g total) by mouth 4 times a day Start medication on 05/22/2020 and continue until completed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-18 10:42:00, ended at 2020-05-18 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)\n\n### Condition\n- Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 12:43:14, ended at 2020-05-19 13:10:48\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-04-20, presumably until 2020-12-11, with intended 0 refill(s). Instructions: take 75 mg by mouth 4 times a day \n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2020-03-27, presumably until 2021-06-05, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-21 10:02:38, ended at 2020-05-21 10:02:53\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- mepivacaine hydrochloride 20 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hypothyroidism\n- Chronic kidney disease stage 2\n- Persistent atrial fibrillation\n- Chronic kidney disease due to hypertension\n- Prediabetes\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- remifentanil 2 MG Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 05:31:00, ended at 2020-05-25 11:37:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Activated clotting time (ACT) of Blood by Coagulation assay: 392 (second)\n- Body height: 5' 10.276\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 79.5 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.38 (unit per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 14.50 (micro-international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Prothrombin time (PT): 17.6 (second)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Collection of venous blood by venipuncture\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure)\n- Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac \n- Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Disorder of cardiovascular system\n- Lumbar radiculopathy\n- Metabolic syndrome X\n- Essential hypertension\n- Hypothyroidism\n- Postoperative state\n- Chronic kidney disease due to hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Paroxysmal atrial fibrillation\n- Primary diagnosis: Persistent atrial fibrillation\n- Abnormal results of cardiovascular function studies\n- Chronic kidney disease stage 2\n- Prediabetes\n- Electrocardiogram abnormal\n- Polyp of colon\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-05-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- benazepril hydrochloride 40 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-08-31, with intended 0 refill(s). Instructions: inject 1 mg/kg subcutaneous (under the skin) daily\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-05-25\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-06-08, with intended 3 refill(s). Instructions: take 400 mg by mouth 2 times a day for 7 days, THEN 200 mg 2 times a day for 7 days, THEN 200 mg daily.\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.91 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-05-27, presumably until 2020-09-22, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-28 00:00:00, ended at 2020-05-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-29, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily as needed\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-05-29, presumably until 2020-05-29, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-07 00:00:00, ended at 2020-06-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-06-08, presumably until 2020-08-15, with intended 11 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-09 11:25:00, ended at 2020-06-09 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-10 00:00:00, ended at 2020-06-10 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-11 00:00:00, ended at 2020-06-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH ONCE DAILY START ON 05/10 AND CONTINUE UNTIL PRESCRIPTION IS COMPLETED.\n- sucralfate 1000 MG Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY START MEDICATION ON 05/22/2020 AND CONTINUE UNTIL COMPLETED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-13 06:00:00, ended at 2020-06-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 08:52:48, ended at 2020-06-16 10:12:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Thyroglobulin Ab [Units/volume] in Serum or Plasma: 2.6 (international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 255 (picogram per milliliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 7 (international unit per milliliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.6 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 32.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 12.770 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.11 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Body height: 5' 10.25\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n- Hyperlipidemia\n- Vitamin B deficiency\n- Vitamin D deficiency\n- Atrial fibrillation\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-20 11:30:00, ended at 2020-06-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Respiratory flow volume loop\n\n### Condition\n- Pulmonary function studies abnormal\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-01 00:00:00, ended at 2020-07-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-04 00:00:00, ended at 2020-07-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-07 00:00:00, ended at 2020-07-07 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-08 00:00:00, ended at 2020-07-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-20 14:35:26, ended at 2020-07-20 14:50:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Prediabetes\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-08-15, presumably until 2020-12-05, with intended 0 refill(s). Instructions: take 0.5 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-29 00:00:00, ended at 2020-08-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-30 10:00:00, ended at 2020-08-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-31 10:18:59, ended at 2020-08-31 11:01:03\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2020-08-31, presumably until 2021-09-05, with intended 12 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-22 09:31:38, ended at 2020-09-22 09:59:53\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-09-22, presumably until 2021-03-30, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-30 07:30:00, ended at 2020-09-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n- Persistent atrial fibrillation\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-16 12:57:09, ended at 2020-11-16 13:31:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Long QT syndrome\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-18 11:00:00, ended at 2020-11-18 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-21 00:00:00, ended at 2020-11-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-01 00:00:00, ended at 2020-12-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-01 09:02:00, ended at 2020-12-01 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-05 00:00:00, ended at 2020-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-12-16, presumably until 2021-03-09, with intended 0 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-19 10:19:56, ended at 2020-12-19 10:30:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism caused by drug\n- Prediabetes\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-17 09:59:16, ended at 2021-01-17 11:01:22\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Paroxysmal atrial fibrillation\n- Coronary atherosclerosis\n- Blood glucose abnormal\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-17, presumably until 2021-03-09, with intended 11 refill(s). Instructions: take 12.5 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-20 06:45:00, ended at 2021-01-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-09 00:00:00, ended at 2021-02-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2021-02-09, presumably until 2021-03-03, with intended 3 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-13 00:00:00, ended at 2021-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Complete atrioventricular block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-15 08:30:00, ended at 2021-02-15 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-22 08:32:00, ended at 2021-02-22 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-03, presumably until 2021-03-10, with intended 1 refill(s). Instructions: take 1 Tab (1 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-03 15:11:00, ended at 2021-03-03 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-08 00:00:00, ended at 2021-03-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, started on 2021-03-09, presumably until 2021-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-10 00:00:00, ended at 2021-03-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-03-10, presumably until 2021-03-20, with intended 1 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-20 00:00:00, ended at 2021-03-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-20, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth as directed (Take 1mg in the morning and 2mg at night)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-30 00:00:00, ended at 2021-03-30 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2021-03-30, presumably until 2021-11-20, with intended 3 refill(s). Instructions: TAKE 1 TAB (50 MCG TOTAL) BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-04 00:00:00, ended at 2021-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-04, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-19 00:00:00, ended at 2021-04-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-19, presumably until 2021-06-05, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every morning AND 1.5 Tabs (3 mg total) Daily at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-19 11:34:11, ended at 2021-04-19 12:12:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-20 06:15:00, ended at 2021-04-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-25 10:16:13, ended at 2021-04-25 11:00:40\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-04-25, presumably until 2021-08-21, with intended 11 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-26 16:08:55, ended at 2021-04-26 16:09:05\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 00:00:00, ended at 2021-04-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Prediabetes\n- Paroxysmal atrial fibrillation\n- Essential hypertension\n- Hypothyroidism\n\n### Drug\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-28, presumably until 2021-04-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 07:16:00, ended at 2021-04-28 11:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 42 (percent)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 14.3 (gram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardioversion, elective, electrical conversion of arrhythmia; external\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Hypothyroidism\n- Rheumatic tricuspid valve regurgitation\n- Atrial fibrillation\n- Typical atrial flutter\n- Atrial flutter\n- Atrial premature complex\n- Persistent atrial fibrillation\n- Lumbar radiculopathy\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Ventricular premature complex\n- Atherosclerosis of coronary artery without angina pectoris\n- Electrocardiogram abnormal\n- Essential hypertension\n- Prediabetes\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-05-14 14:29:00, ended at 2021-05-14 18:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.6 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.28 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Tachycardia\n- Essential hypertension\n- Hypothyroidism\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-14\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-16, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-15 00:00:00, ended at 2021-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-16 00:00:00, ended at 2021-05-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-16, presumably until 2021-06-29, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth 2 times a day as needed For AFib episodes\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-23 00:00:00, ended at 2021-05-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-06-13, presumably until 2021-11-28, with intended 0 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth daily Start 4 days pre-procedure, and continue 30 days after, no refills. First dose 08/14/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-25 00:00:00, ended at 2021-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-31 13:29:00, ended at 2021-05-31 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-02 00:00:00, ended at 2021-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-06 00:00:00, ended at 2021-06-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 11:43:13, ended at 2019-12-21 13:57:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2019-03-04, presumably until 2020-12-16, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:00:00, ended at 2019-12-21 14:42:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Persistent atrial fibrillation\n- Chronic atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:43:00, ended at 2019-12-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-28 00:00:00, ended at 2020-01-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-29 07:00:00, ended at 2020-01-29 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Ventricular tachycardia\n- Atrial flutter\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily Start on 05/10 and continue until prescription is completed.\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (1 g total) by mouth 4 times a day Start medication on 05/22/2020 and continue until completed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-18 10:42:00, ended at 2020-05-18 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)\n\n### Condition\n- Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 12:43:14, ended at 2020-05-19 13:10:48\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-04-20, presumably until 2020-12-11, with intended 0 refill(s). Instructions: take 75 mg by mouth 4 times a day \n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2020-03-27, presumably until 2021-06-05, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-21 10:02:38, ended at 2020-05-21 10:02:53\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- mepivacaine hydrochloride 20 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hypothyroidism\n- Chronic kidney disease stage 2\n- Persistent atrial fibrillation\n- Chronic kidney disease due to hypertension\n- Prediabetes\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- remifentanil 2 MG Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 05:31:00, ended at 2020-05-25 11:37:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Activated clotting time (ACT) of Blood by Coagulation assay: 392 (second)\n- Body height: 5' 10.276\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 79.5 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.38 (unit per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 14.50 (micro-international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Prothrombin time (PT): 17.6 (second)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Collection of venous blood by venipuncture\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure)\n- Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac \n- Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Disorder of cardiovascular system\n- Lumbar radiculopathy\n- Metabolic syndrome X\n- Essential hypertension\n- Hypothyroidism\n- Postoperative state\n- Chronic kidney disease due to hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Paroxysmal atrial fibrillation\n- Primary diagnosis: Persistent atrial fibrillation\n- Abnormal results of cardiovascular function studies\n- Chronic kidney disease stage 2\n- Prediabetes\n- Electrocardiogram abnormal\n- Polyp of colon\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-05-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- benazepril hydrochloride 40 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-08-31, with intended 0 refill(s). Instructions: inject 1 mg/kg subcutaneous (under the skin) daily\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-05-25\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-06-08, with intended 3 refill(s). Instructions: take 400 mg by mouth 2 times a day for 7 days, THEN 200 mg 2 times a day for 7 days, THEN 200 mg daily.\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.91 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-05-27, presumably until 2020-09-22, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-28 00:00:00, ended at 2020-05-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-29, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily as needed\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-05-29, presumably until 2020-05-29, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-07 00:00:00, ended at 2020-06-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-06-08, presumably until 2020-08-15, with intended 11 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-09 11:25:00, ended at 2020-06-09 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-10 00:00:00, ended at 2020-06-10 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-11 00:00:00, ended at 2020-06-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH ONCE DAILY START ON 05/10 AND CONTINUE UNTIL PRESCRIPTION IS COMPLETED.\n- sucralfate 1000 MG Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY START MEDICATION ON 05/22/2020 AND CONTINUE UNTIL COMPLETED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-13 06:00:00, ended at 2020-06-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 08:52:48, ended at 2020-06-16 10:12:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Thyroglobulin Ab [Units/volume] in Serum or Plasma: 2.6 (international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 255 (picogram per milliliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 7 (international unit per milliliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.6 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 32.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 12.770 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.11 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Body height: 5' 10.25\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n- Hyperlipidemia\n- Vitamin B deficiency\n- Vitamin D deficiency\n- Atrial fibrillation\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-20 11:30:00, ended at 2020-06-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Respiratory flow volume loop\n\n### Condition\n- Pulmonary function studies abnormal\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-01 00:00:00, ended at 2020-07-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-04 00:00:00, ended at 2020-07-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-07 00:00:00, ended at 2020-07-07 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-08 00:00:00, ended at 2020-07-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-20 14:35:26, ended at 2020-07-20 14:50:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Prediabetes\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-08-15, presumably until 2020-12-05, with intended 0 refill(s). Instructions: take 0.5 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-29 00:00:00, ended at 2020-08-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-30 10:00:00, ended at 2020-08-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-31 10:18:59, ended at 2020-08-31 11:01:03\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2020-08-31, presumably until 2021-09-05, with intended 12 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-22 09:31:38, ended at 2020-09-22 09:59:53\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-09-22, presumably until 2021-03-30, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-30 07:30:00, ended at 2020-09-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n- Persistent atrial fibrillation\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-16 12:57:09, ended at 2020-11-16 13:31:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Long QT syndrome\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-18 11:00:00, ended at 2020-11-18 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-21 00:00:00, ended at 2020-11-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-01 00:00:00, ended at 2020-12-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-01 09:02:00, ended at 2020-12-01 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-05 00:00:00, ended at 2020-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-12-16, presumably until 2021-03-09, with intended 0 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-19 10:19:56, ended at 2020-12-19 10:30:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism caused by drug\n- Prediabetes\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-17 09:59:16, ended at 2021-01-17 11:01:22\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Paroxysmal atrial fibrillation\n- Coronary atherosclerosis\n- Blood glucose abnormal\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-17, presumably until 2021-03-09, with intended 11 refill(s). Instructions: take 12.5 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-20 06:45:00, ended at 2021-01-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-09 00:00:00, ended at 2021-02-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2021-02-09, presumably until 2021-03-03, with intended 3 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-13 00:00:00, ended at 2021-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Complete atrioventricular block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-15 08:30:00, ended at 2021-02-15 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-22 08:32:00, ended at 2021-02-22 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-03, presumably until 2021-03-10, with intended 1 refill(s). Instructions: take 1 Tab (1 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-03 15:11:00, ended at 2021-03-03 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-08 00:00:00, ended at 2021-03-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, started on 2021-03-09, presumably until 2021-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-10 00:00:00, ended at 2021-03-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-03-10, presumably until 2021-03-20, with intended 1 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-20 00:00:00, ended at 2021-03-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-20, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth as directed (Take 1mg in the morning and 2mg at night)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-30 00:00:00, ended at 2021-03-30 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2021-03-30, presumably until 2021-11-20, with intended 3 refill(s). Instructions: TAKE 1 TAB (50 MCG TOTAL) BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-04 00:00:00, ended at 2021-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-04, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-19 00:00:00, ended at 2021-04-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-19, presumably until 2021-06-05, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every morning AND 1.5 Tabs (3 mg total) Daily at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-19 11:34:11, ended at 2021-04-19 12:12:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-20 06:15:00, ended at 2021-04-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-25 10:16:13, ended at 2021-04-25 11:00:40\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-04-25, presumably until 2021-08-21, with intended 11 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-26 16:08:55, ended at 2021-04-26 16:09:05\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 00:00:00, ended at 2021-04-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Prediabetes\n- Paroxysmal atrial fibrillation\n- Essential hypertension\n- Hypothyroidism\n\n### Drug\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-28, presumably until 2021-04-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 07:16:00, ended at 2021-04-28 11:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 42 (percent)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 14.3 (gram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardioversion, elective, electrical conversion of arrhythmia; external\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Hypothyroidism\n- Rheumatic tricuspid valve regurgitation\n- Atrial fibrillation\n- Typical atrial flutter\n- Atrial flutter\n- Atrial premature complex\n- Persistent atrial fibrillation\n- Lumbar radiculopathy\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Ventricular premature complex\n- Atherosclerosis of coronary artery without angina pectoris\n- Electrocardiogram abnormal\n- Essential hypertension\n- Prediabetes\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-05-14 14:29:00, ended at 2021-05-14 18:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.6 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.28 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Tachycardia\n- Essential hypertension\n- Hypothyroidism\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-14\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-16, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-15 00:00:00, ended at 2021-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-16 00:00:00, ended at 2021-05-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-16, presumably until 2021-06-29, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth 2 times a day as needed For AFib episodes\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-23 00:00:00, ended at 2021-05-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-06-13, presumably until 2021-11-28, with intended 0 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth daily Start 4 days pre-procedure, and continue 30 days after, no refills. First dose 08/14/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-25 00:00:00, ended at 2021-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-31 13:29:00, ended at 2021-05-31 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-02 00:00:00, ended at 2021-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-06 00:00:00, ended at 2021-06-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8bcd6b70cb8efffe2e11d04b49180d1e00130b055ee387b1a6780d0ca59f460f", "prompt_hash": "7af4ba177dc4eb929d4477b1a91ffb81caf5a0387c6fc241acf1e1dcc7aca115", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 2, "doc": {"person_id": 115967769, "visit_occurrence_id": 159320772, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2020-05-17 00:00:00", "visit_end_datetime": "2020-05-17 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n", "approximate_token_count": 123, "patient_first_visit_date": "2012-03-31 14:46:00", "patient_last_visit_date": "2023-02-06 10:56:09", "end_obs_date": "2021-05-17", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 129, "cumulated_visit_num": 129, "cumulated_approximate_token_count": 24713, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "158c09c66bbc2808a3e20c763d96a3c5eed1be8e0ff71a701fa5d42ab1404da8", "prompt_hash": "1771fa17bd5e5a010438dbe5a63593003aeec926445db683565cbe22737da12b", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 3, "doc": {"person_id": 115967868, "visit_occurrence_id": 45095824, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2011-08-30 00:00:00", "visit_end_datetime": "2011-08-30 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2009-07-11 13:00:00", "patient_last_visit_date": "2021-07-02 00:00:00", "end_obs_date": "2012-08-29", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 5721, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-11 13:00:00, ended at 2009-07-11 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2012-03-24. Instructions: take by mouth 2 times a day. \n- valsartan 160 MG Oral Tablet, through Oral route, presumably until 2013-05-04. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth daily. \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-07-19. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-18 11:30:00, ended at 2009-07-18 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. Call if lightheaded\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-20 10:54:00, ended at 2009-07-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-25 09:45:00, ended at 2009-07-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 12.3 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- atenolol 50 MG Oral Tablet, through Oral route, presumably until 2010-02-20. Instructions: take by mouth. \n- allopurinol 300 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- terazosin 5 MG Oral Tablet, through Oral route. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-07-26 08:45:00, ended at 2009-07-31 12:18:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Prothrombin time (PT): 16.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 60.5 (millimeter mercury column)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 640 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Alcohol abuse\n- Complication of surgical procedure\n- Gout\n- Disorder of lung\n- Drug abuse, continuous\n- Primary malignant neoplasm of lower lobe, bronchus or lung\n- Hyperlipidemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-27, presumably until 2009-07-31\n- terazosin 5 MG Oral Capsule, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2009-07-30, presumably until 2009-07-31\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-31\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2009-07-27, presumably until 2009-07-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-07-28, presumably until 2009-07-30\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-07-30, presumably until 2010-02-20, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-07-27, presumably until 2009-07-31\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-29\n- valsartan 160 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-07-26, presumably until 2009-07-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2009-07-30, presumably until 2009-07-31\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-07-26, presumably until 2009-07-30\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-31\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-07-27, presumably until 2009-07-27\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-07-28, presumably until 2009-07-31\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-31, presumably until 2010-01-27, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-08-12 13:49:00, ended at 2009-08-12 19:26:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.08 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Generalized aches and pains\n- Chest pain\n\n### Drug\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-12, presumably until 2009-08-12\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-08-12, presumably until 2009-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-22 10:30:00, ended at 2009-08-22 10:42:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-25 16:07:00, ended at 2009-08-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 08:55:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Pleural effusion\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:14:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route. Instructions: take by mouth daily. \n- carvedilol 12.5 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-01 00:00:00, ended at 2010-08-01 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-21 08:25:00, ended at 2010-08-21 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Disorder of lung\n- Lung field abnormal\n- Pleural effusion\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-28 10:12:00, ended at 2010-08-28 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-07 16:59:00, ended at 2011-02-07 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 13:36:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Cervical spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-11 08:11:00, ended at 2011-02-11 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Pleural effusion\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-18 09:50:46, ended at 2011-02-18 15:26:56\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-26 09:25:00, ended at 2011-02-26 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-01 09:40:00, ended at 2011-03-01 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Degeneration of intervertebral disc\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-06 00:00:00, ended at 2011-03-06 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-12 14:44:00, ended at 2011-08-12 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 09:23:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 09:45:00, ended at 2011-08-27 10:37:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 10:38:00, ended at 2011-08-27 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-11 13:00:00, ended at 2009-07-11 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2012-03-24. Instructions: take by mouth 2 times a day. \n- valsartan 160 MG Oral Tablet, through Oral route, presumably until 2013-05-04. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth daily. \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-07-19. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-18 11:30:00, ended at 2009-07-18 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. Call if lightheaded\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-20 10:54:00, ended at 2009-07-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-25 09:45:00, ended at 2009-07-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 12.3 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- atenolol 50 MG Oral Tablet, through Oral route, presumably until 2010-02-20. Instructions: take by mouth. \n- allopurinol 300 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- terazosin 5 MG Oral Tablet, through Oral route. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-07-26 08:45:00, ended at 2009-07-31 12:18:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Prothrombin time (PT): 16.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 60.5 (millimeter mercury column)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 640 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Alcohol abuse\n- Complication of surgical procedure\n- Gout\n- Disorder of lung\n- Drug abuse, continuous\n- Primary malignant neoplasm of lower lobe, bronchus or lung\n- Hyperlipidemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-27, presumably until 2009-07-31\n- terazosin 5 MG Oral Capsule, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2009-07-30, presumably until 2009-07-31\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-31\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2009-07-27, presumably until 2009-07-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-07-28, presumably until 2009-07-30\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-07-30, presumably until 2010-02-20, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-07-27, presumably until 2009-07-31\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-29\n- valsartan 160 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-07-26, presumably until 2009-07-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2009-07-30, presumably until 2009-07-31\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-07-26, presumably until 2009-07-30\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-31\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-07-27, presumably until 2009-07-27\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-07-28, presumably until 2009-07-31\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-31, presumably until 2010-01-27, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-08-12 13:49:00, ended at 2009-08-12 19:26:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.08 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Generalized aches and pains\n- Chest pain\n\n### Drug\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-12, presumably until 2009-08-12\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-08-12, presumably until 2009-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-22 10:30:00, ended at 2009-08-22 10:42:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-25 16:07:00, ended at 2009-08-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 08:55:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Pleural effusion\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:14:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route. Instructions: take by mouth daily. \n- carvedilol 12.5 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-01 00:00:00, ended at 2010-08-01 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-21 08:25:00, ended at 2010-08-21 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Disorder of lung\n- Lung field abnormal\n- Pleural effusion\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-28 10:12:00, ended at 2010-08-28 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-07 16:59:00, ended at 2011-02-07 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 13:36:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Cervical spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-11 08:11:00, ended at 2011-02-11 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Pleural effusion\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-18 09:50:46, ended at 2011-02-18 15:26:56\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-26 09:25:00, ended at 2011-02-26 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-01 09:40:00, ended at 2011-03-01 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Degeneration of intervertebral disc\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-06 00:00:00, ended at 2011-03-06 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-12 14:44:00, ended at 2011-08-12 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 09:23:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 09:45:00, ended at 2011-08-27 10:37:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 10:38:00, ended at 2011-08-27 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3e234eef2f4784129299218fc963ede935b7b9ed6a95e0bf1129d432342fe88c", "prompt_hash": "aa2601d7668ee985a3cfe9e73108e7950907e1a05c2e184780a4bfc9dba00dac", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115968081, "visit_occurrence_id": 180687774, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2021-05-08 06:57:00", "visit_end_datetime": "2021-05-08 23:59:00", "visit_length_in_hours": 17.033333333333335, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 118, "patient_first_visit_date": "2011-01-09 10:37:00", "patient_last_visit_date": "2023-02-04 11:16:39", "end_obs_date": "2022-05-08", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "recurrent", "liver_cancer_one_year_diagnosis": 1, "visit_sequence_number": 37, "cumulated_visit_num": 37, "cumulated_approximate_token_count": 9832, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-01-09 10:37:00, ended at 2011-01-29 15:45:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.7 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 415 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 32.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 96 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.73 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 61.8 (second)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Base deficit in Blood: 9.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Aortocoronary bypass of two coronary arteries\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Catheterization of both left and right heart\n- Operative external blood circulation\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary angiography\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of intra-aortic balloon counterpulsation\n- Single internal mammary-coronary artery bypass\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n\n### Condition\n- Congestive heart failure\n- Obesity\n- Obstructive sleep apnea syndrome\n- Postprocedural state finding\n- Acute respiratory failure\n- Peripheral vascular disease\n- Pulmonary congestion and hypostasis\n- Brachial radiculitis\n- Coronary arteriosclerosis\n- Essential hypertension\n- Glaucoma\n- Leukocytosis\n- Primary diagnosis: Acute myocardial infarction\n- Aortocoronary bypass graft present\n- Cardiomegaly\n- Hyperlipidemia\n- Acute combined systolic and diastolic heart failure\n- Cardiac arrhythmia\n- Chronic systolic heart failure\n- Hemorrhoids\n- Nuclear senile cataract\n- Sequelae of cardiovascular disorders\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction of anterolateral wall\n- Chronic ischemic heart disease\n- Pleural effusion\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-02-15, with quantity of 15.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-01-20, presumably until 2011-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-01-21\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-01-28\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-01-11, presumably until 2011-01-11\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-26\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-04-19. Instructions: take 25 mg by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-01-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-20\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2011-01-19, presumably until 2011-01-23\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2011-01-12, presumably until 2011-01-28\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2011-01-27, presumably until 2011-04-19, with quantity of 1.0, with intended 0 refill(s). Instructions: insert into the rectum as needed for Anorectal itching/discomfort. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2012-01-29, with quantity of 120.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2011-01-09, presumably until 2011-01-09\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-01-12, presumably until 2011-01-28\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-01-14, presumably until 2012-01-29, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-01-27, presumably until 2012-01-29, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-13, presumably until 2020-04-28. Instructions: inject subcutaneous (under the skin). \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-29. Instructions: take by mouth.\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-01-17, presumably until 2011-01-29\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-01-13, presumably until 2011-01-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-01-09, presumably until 2011-01-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-01-28. Instructions: take 20 mg by mouth daily.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-01-11, presumably until 2011-01-14\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-09, presumably until 2022-08-20. Instructions: inject subcutaneous (under the skin) 4 times a day before meals and bedtime. \n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-26\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-13\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2011-01-14, presumably until 2011-01-14\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2011-01-13, presumably until 2011-01-13\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-01-29, with quantity of 90.0, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily. Please have INR levels checked on Monday 02/01/2011 \n- pravastatin sodium 10 MG Oral Tablet, through Oral route, presumably until 2011-02-15. Instructions: take 20 mg by mouth daily. \n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2011-01-25, presumably until 2011-01-25\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-01-13, presumably until 2011-04-19, with quantity of 60.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed \n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2011-01-11, presumably until 2011-01-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2011-02-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-01-12, presumably until 2011-01-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-23, presumably until 2011-04-19, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-10 14:38:57, ended at 2011-01-10 15:15:45\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-18 09:29:44, ended at 2011-01-18 10:42:10\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-29 10:00:00, ended at 2011-01-29 23:59:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-29 00:00:00, ended at 2020-01-29 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cancer Ag 19-9 [Units/volume] in Serum or Plasma: 2 (unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-01 08:29:50, ended at 2020-02-01 10:34:41\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2020-01-28, presumably until 2020-01-28, with intended 0 refill(s). Instructions: take 1 Tablet (300 mg total) by mouth daily\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-23, presumably until 2019-10-23, with intended 0 refill(s). Instructions: take 1 Tablet (20 mg total) by mouth AM\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-12, presumably until 2022-11-09, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-10-25, presumably until 2022-03-01, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- vitamin B complex, through Oral route, started on 2012-07-25, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Capsule by mouth daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2019-07-23, presumably until 2019-07-23, with intended 0 refill(s). Instructions: take 1 Tablet (150 mg total) by mouth AM\n- dorzolamide 20 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-08-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day\n- spironolactone 25 MG Oral Tablet, started on 2017-08-15, presumably until 2017-08-15, with intended 0 refill(s). Instructions: Take one tablet by mouth one time daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-08-19, presumably until 2017-08-19, with intended 0 refill(s). Instructions: inject 60 Units subcutaneous (under the skin) 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-30, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-01-07, presumably until 2020-01-07, with intended 0 refill(s). Instructions: inject subcutaneous (under the skin) every 7 days Every Mondays\n- rosuvastatin calcium 20 MG Oral Tablet, started on 2019-08-24, presumably until 2019-08-24, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2019-11-15, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-01 10:33:00, ended at 2020-02-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.43 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 69.0 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 07:12:00, ended at 2020-03-31 08:24:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Liver cell carcinoma\n- Lumbar spondylosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 08:25:00, ended at 2020-03-31 10:25:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 13:22:00, ended at 2020-03-31 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Portal vein thrombosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-18 10:04:44, ended at 2020-04-18 10:16:59\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-22 07:47:00, ended at 2020-04-22 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n\n### Condition\n- Postoperative state\n- Steatosis of liver\n- Disorder of digestive system\n- Hepatosplenomegaly\n- Liver cell carcinoma\n- Acquired absence of organ\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 09:33:22, ended at 2020-04-28 10:35:04\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Malignant neoplasm of liver\n- Traumatic or non-traumatic injury\n- Obstructive sleep apnea syndrome\n- Generalized ischemic myocardial dysfunction\n- Hyperlipidemia\n- Primary diagnosis: COVID-19\n- Liver cell carcinoma\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, presumably until 2020-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Liver cell carcinoma\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- cefazolin 1000 MG Injection, started on 2020-05-01, presumably until 2020-05-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-01 08:40:00, ended at 2020-05-01 19:30:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Body height: 5' 6\" (inch (US))\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 223 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- Ablation, 1 or more liver tumor(s), percutaneous, radiofrequency\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aortocoronary bypass graft present\n- Steatosis of liver\n- Hyperlipidemia\n- Old myocardial infarction\n- Supraventricular tachycardia\n- Chronic systolic heart failure\n- Primary diagnosis: Liver cell carcinoma\n- Generalized ischemic myocardial dysfunction\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Obesity\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-04 10:32:19, ended at 2020-07-04 10:56:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n- Portal vein thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-05 07:00:00, ended at 2020-08-05 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:46:06, ended at 2020-08-06 09:13:34\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-07 00:00:00, ended at 2020-08-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 10:36:58, ended at 2020-08-15 11:02:37\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Liver\n- Portal vein thrombosis\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-05 07:10:00, ended at 2020-11-05 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 09:54:20, ended at 2020-11-14 10:11:20\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-12 00:00:00, ended at 2021-01-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.56 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-12 12:59:00, ended at 2021-02-12 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Portal hypertension\n- Splenomegaly\n- Liver cell carcinoma\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-13 10:28:20, ended at 2021-02-13 10:49:11\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-01-09 10:37:00, ended at 2011-01-29 15:45:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.7 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 415 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 32.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 96 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.73 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 61.8 (second)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Base deficit in Blood: 9.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Aortocoronary bypass of two coronary arteries\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Catheterization of both left and right heart\n- Operative external blood circulation\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary angiography\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of intra-aortic balloon counterpulsation\n- Single internal mammary-coronary artery bypass\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n\n### Condition\n- Congestive heart failure\n- Obesity\n- Obstructive sleep apnea syndrome\n- Postprocedural state finding\n- Acute respiratory failure\n- Peripheral vascular disease\n- Pulmonary congestion and hypostasis\n- Brachial radiculitis\n- Coronary arteriosclerosis\n- Essential hypertension\n- Glaucoma\n- Leukocytosis\n- Primary diagnosis: Acute myocardial infarction\n- Aortocoronary bypass graft present\n- Cardiomegaly\n- Hyperlipidemia\n- Acute combined systolic and diastolic heart failure\n- Cardiac arrhythmia\n- Chronic systolic heart failure\n- Hemorrhoids\n- Nuclear senile cataract\n- Sequelae of cardiovascular disorders\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction of anterolateral wall\n- Chronic ischemic heart disease\n- Pleural effusion\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-02-15, with quantity of 15.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-01-20, presumably until 2011-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-01-21\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-01-28\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-01-11, presumably until 2011-01-11\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-26\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-04-19. Instructions: take 25 mg by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-01-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-20\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2011-01-19, presumably until 2011-01-23\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2011-01-12, presumably until 2011-01-28\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2011-01-27, presumably until 2011-04-19, with quantity of 1.0, with intended 0 refill(s). Instructions: insert into the rectum as needed for Anorectal itching/discomfort. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2012-01-29, with quantity of 120.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2011-01-09, presumably until 2011-01-09\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-01-12, presumably until 2011-01-28\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-01-14, presumably until 2012-01-29, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-01-27, presumably until 2012-01-29, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-13, presumably until 2020-04-28. Instructions: inject subcutaneous (under the skin). \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-29. Instructions: take by mouth.\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-01-17, presumably until 2011-01-29\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-01-13, presumably until 2011-01-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-01-09, presumably until 2011-01-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-01-28. Instructions: take 20 mg by mouth daily.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-01-11, presumably until 2011-01-14\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-09, presumably until 2022-08-20. Instructions: inject subcutaneous (under the skin) 4 times a day before meals and bedtime. \n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-26\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-13\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2011-01-14, presumably until 2011-01-14\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2011-01-13, presumably until 2011-01-13\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-01-29, with quantity of 90.0, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily. Please have INR levels checked on Monday 02/01/2011 \n- pravastatin sodium 10 MG Oral Tablet, through Oral route, presumably until 2011-02-15. Instructions: take 20 mg by mouth daily. \n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2011-01-25, presumably until 2011-01-25\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-01-13, presumably until 2011-04-19, with quantity of 60.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed \n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2011-01-11, presumably until 2011-01-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2011-02-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-01-12, presumably until 2011-01-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-23, presumably until 2011-04-19, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-10 14:38:57, ended at 2011-01-10 15:15:45\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-18 09:29:44, ended at 2011-01-18 10:42:10\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-29 10:00:00, ended at 2011-01-29 23:59:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-29 00:00:00, ended at 2020-01-29 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cancer Ag 19-9 [Units/volume] in Serum or Plasma: 2 (unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-01 08:29:50, ended at 2020-02-01 10:34:41\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2020-01-28, presumably until 2020-01-28, with intended 0 refill(s). Instructions: take 1 Tablet (300 mg total) by mouth daily\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-23, presumably until 2019-10-23, with intended 0 refill(s). Instructions: take 1 Tablet (20 mg total) by mouth AM\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-12, presumably until 2022-11-09, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-10-25, presumably until 2022-03-01, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- vitamin B complex, through Oral route, started on 2012-07-25, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Capsule by mouth daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2019-07-23, presumably until 2019-07-23, with intended 0 refill(s). Instructions: take 1 Tablet (150 mg total) by mouth AM\n- dorzolamide 20 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-08-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day\n- spironolactone 25 MG Oral Tablet, started on 2017-08-15, presumably until 2017-08-15, with intended 0 refill(s). Instructions: Take one tablet by mouth one time daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-08-19, presumably until 2017-08-19, with intended 0 refill(s). Instructions: inject 60 Units subcutaneous (under the skin) 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-30, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-01-07, presumably until 2020-01-07, with intended 0 refill(s). Instructions: inject subcutaneous (under the skin) every 7 days Every Mondays\n- rosuvastatin calcium 20 MG Oral Tablet, started on 2019-08-24, presumably until 2019-08-24, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2019-11-15, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-01 10:33:00, ended at 2020-02-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.43 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 69.0 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 07:12:00, ended at 2020-03-31 08:24:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Liver cell carcinoma\n- Lumbar spondylosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 08:25:00, ended at 2020-03-31 10:25:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 13:22:00, ended at 2020-03-31 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Portal vein thrombosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-18 10:04:44, ended at 2020-04-18 10:16:59\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-22 07:47:00, ended at 2020-04-22 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n\n### Condition\n- Postoperative state\n- Steatosis of liver\n- Disorder of digestive system\n- Hepatosplenomegaly\n- Liver cell carcinoma\n- Acquired absence of organ\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 09:33:22, ended at 2020-04-28 10:35:04\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Malignant neoplasm of liver\n- Traumatic or non-traumatic injury\n- Obstructive sleep apnea syndrome\n- Generalized ischemic myocardial dysfunction\n- Hyperlipidemia\n- Primary diagnosis: COVID-19\n- Liver cell carcinoma\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, presumably until 2020-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Liver cell carcinoma\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- cefazolin 1000 MG Injection, started on 2020-05-01, presumably until 2020-05-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-01 08:40:00, ended at 2020-05-01 19:30:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Body height: 5' 6\" (inch (US))\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 223 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- Ablation, 1 or more liver tumor(s), percutaneous, radiofrequency\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aortocoronary bypass graft present\n- Steatosis of liver\n- Hyperlipidemia\n- Old myocardial infarction\n- Supraventricular tachycardia\n- Chronic systolic heart failure\n- Primary diagnosis: Liver cell carcinoma\n- Generalized ischemic myocardial dysfunction\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Obesity\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-04 10:32:19, ended at 2020-07-04 10:56:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n- Portal vein thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-05 07:00:00, ended at 2020-08-05 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:46:06, ended at 2020-08-06 09:13:34\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-07 00:00:00, ended at 2020-08-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 10:36:58, ended at 2020-08-15 11:02:37\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Liver\n- Portal vein thrombosis\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-05 07:10:00, ended at 2020-11-05 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 09:54:20, ended at 2020-11-14 10:11:20\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-12 00:00:00, ended at 2021-01-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.56 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-12 12:59:00, ended at 2021-02-12 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Portal hypertension\n- Splenomegaly\n- Liver cell carcinoma\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-13 10:28:20, ended at 2021-02-13 10:49:11\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "abfba416c551706ccd9b2ad7a2e8092272b4a5a72b4641e93b07d59ef6160e50", "prompt_hash": "a79fd1eb098d266f0497ded57b11027237601ec6c91e55197f0d4af8f1605b04", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115968945, "visit_occurrence_id": 41847305, "death_date": null, "visit_concept_name": "Emergency Room and Inpatient Visit", "visit_start_datetime": "2010-11-30 16:02:00", "visit_end_datetime": "2010-12-05 11:55:00", "visit_length_in_hours": 115.88333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n", "approximate_token_count": 2316, "patient_first_visit_date": "2008-07-01 02:25:00", "patient_last_visit_date": "2013-11-26 07:55:00", "end_obs_date": "2011-12-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 50, "cumulated_visit_num": 50, "cumulated_approximate_token_count": 16603, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d8c873cd38fa139f2c72860e17bbaed4ce73aaeda7054f32e1a655755b2f4620", "prompt_hash": "26ded1e70d5c889a0b9455a1a56badd77951005a7b0bed8589b8a3b24b70d8d1", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115969163, "visit_occurrence_id": 123629933, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2018-09-26 13:59:08", "visit_end_datetime": "2018-09-26 15:02:23", "visit_length_in_hours": 1.0541666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:59:08, ended at 2018-09-26 15:02:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemorrhage of rectum and anus\n- Primary diagnosis: Nausea\n\n### Drug\n- colesevelam hydrochloride 625 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n", "approximate_token_count": 139, "patient_first_visit_date": "2015-01-29 07:01:00", "patient_last_visit_date": "2022-10-23 09:37:25", "end_obs_date": "2019-09-26", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 8, "cumulated_visit_num": 8, "cumulated_approximate_token_count": 7349, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-29 07:01:00, ended at 2015-01-30 16:25:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.95 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 182 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 53.3 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein\n- Injection procedure for extremity venography (including introduction of needle or intracatheter)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up ca\n- Procedure on single vessel\n- Angioplasty of other non-coronary vessel(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Injection or infusion of thrombolytic agent\n- Introduction of catheter, superior or inferior vena cava\n- Insertion of one vascular stent\n- Venography, extremity, unilateral, radiological supervision and interpretation\n- Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day\n- Collection of venous blood by venipuncture\n- Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s)\n\n### Condition\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Primary diagnosis: Acute deep vein thrombosis of lower limb\n- Swelling of limb\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth Patient takes every day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 50 mcg by mouth every morning before breakfast. Take 100 mcg by mouth daily.\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-01-30\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 25 mg by mouth every 6 hours as needed.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-01-22, presumably until 2019-02-06, with intended 0 refill(s). Instructions: take 20 mg by mouth 2 times a day.\n- paroxetine hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take  by mouth.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-05-22, with intended 0 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2015-01-30, presumably until 2015-01-30\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2015-01-29, presumably until 2015-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-22 10:11:49, ended at 2015-05-22 10:58:25\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.157\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling of limb\n\n### Drug\n- warfarin sodium 3 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take 3 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 13:35:00, ended at 2017-04-01 13:53:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Abnormal urine\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 00:00:00, ended at 2017-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Dyspnea\n- Hypothyroidism\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-04-19, presumably until 2017-04-19\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- cefazolin 1000 MG Injection, started on 2017-04-19, presumably until 2017-04-19\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 06:24:00, ended at 2017-04-28 11:39:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.55 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.48 (thousand per microliter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 44.5 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.0 (second)\n- Bicarbonate [Moles/volume] in Specimen: 26.5 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 48.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.66 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Left ventricular Ejection fraction: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Base excess in Arterial blood by calculation: 1.7 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Prothrombin time (PT): 20.4 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 5.1 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 61 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 19.1 (nanogram per milliliter)\n\n### Procedure\n- Repair Atrial Septum, Open Approach\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Excision of Right Saphenous Vein, Open Approach\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Bypass Coronary Artery, One Artery from Aorta with Autologous Venous Tissue, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Supplement Mitral Valve with Synthetic Substitute, Open Approach\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Controlled ventilation procedure and therapy, initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Performance of Cardiac Output, Continuous\n\n### Condition\n- Chronic kidney disease stage 1\n- Congestive heart failure\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Atrial premature complex\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Abdominal pain\n- Low back pain\n- Rheumatic disease of mitral valve\n- Right bundle branch block\n- Acute posthemorrhagic anemia\n- Ascorbic acid deficiency\n- Combined systolic and diastolic dysfunction\n- Compression of vein\n- Gastroesophageal reflux disease without esophagitis\n- Mitral valve prolapse\n- Pneumothorax\n- Conduction disorder of the heart\n- Hypothyroidism\n- Major depression, single episode\n- Anxiety disorder\n- Atrial fibrillation\n- Chronic pain\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n- Urinary tract infectious disease\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial septal defect\n- Bifascicular block\n- Chronic atrial fibrillation\n- Chronic combined systolic and diastolic heart failure\n- Headache\n- Nausea\n- Non-rheumatic mitral valve disease\n- Paroxysmal atrial fibrillation\n- Pleural effusion\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-23\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2017-04-28\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-21\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-05-03, with intended 0 refill(s). Instructions: take 1 Aminian by mouth every 12 hours for 5 days , first dose was on 3-28 at night, last dose will be 4-3\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-04-19, presumably until 2017-04-22\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-22\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-22\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban, started on 2017-04-27, presumably until 2017-05-20, with intended 0 refill(s). Instructions: Take 1 round (15 mg) tab twice daily with food for 21 days then 1 triangle tab (20 mg) daily with food\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-27\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-04-20, presumably until 2017-04-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-28\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every morning before breakfast\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-04-20, presumably until 2017-04-25\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-04-21, presumably until 2017-04-21\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-04-20, presumably until 2017-04-24\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-23\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-04-26, presumably until 2017-04-27\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-21\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-04-20, presumably until 2017-04-21\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2017-04-20, presumably until 2017-04-27\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-20\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-04-24, presumably until 2017-04-26\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compression of vein\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2017-04-27, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-20 11:02:41, ended at 2017-05-20 12:11:36\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.22\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- rivaroxaban 20 MG Oral Tablet, through Oral route, presumably until 2020-07-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 81 mg by mouth every Monday, Wednesday and Friday\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:59:08, ended at 2018-09-26 15:02:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemorrhage of rectum and anus\n- Primary diagnosis: Nausea\n\n### Drug\n- colesevelam hydrochloride 625 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-29 07:01:00, ended at 2015-01-30 16:25:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.95 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 182 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 53.3 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein\n- Injection procedure for extremity venography (including introduction of needle or intracatheter)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up ca\n- Procedure on single vessel\n- Angioplasty of other non-coronary vessel(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Injection or infusion of thrombolytic agent\n- Introduction of catheter, superior or inferior vena cava\n- Insertion of one vascular stent\n- Venography, extremity, unilateral, radiological supervision and interpretation\n- Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day\n- Collection of venous blood by venipuncture\n- Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s)\n\n### Condition\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Primary diagnosis: Acute deep vein thrombosis of lower limb\n- Swelling of limb\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth Patient takes every day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 50 mcg by mouth every morning before breakfast. Take 100 mcg by mouth daily.\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-01-30\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 25 mg by mouth every 6 hours as needed.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-01-22, presumably until 2019-02-06, with intended 0 refill(s). Instructions: take 20 mg by mouth 2 times a day.\n- paroxetine hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take  by mouth.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-05-22, with intended 0 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2015-01-30, presumably until 2015-01-30\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2015-01-29, presumably until 2015-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-22 10:11:49, ended at 2015-05-22 10:58:25\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.157\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling of limb\n\n### Drug\n- warfarin sodium 3 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take 3 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 13:35:00, ended at 2017-04-01 13:53:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Abnormal urine\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 00:00:00, ended at 2017-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Dyspnea\n- Hypothyroidism\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-04-19, presumably until 2017-04-19\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- cefazolin 1000 MG Injection, started on 2017-04-19, presumably until 2017-04-19\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 06:24:00, ended at 2017-04-28 11:39:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.55 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.48 (thousand per microliter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 44.5 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.0 (second)\n- Bicarbonate [Moles/volume] in Specimen: 26.5 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 48.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.66 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Left ventricular Ejection fraction: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Base excess in Arterial blood by calculation: 1.7 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Prothrombin time (PT): 20.4 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 5.1 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 61 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 19.1 (nanogram per milliliter)\n\n### Procedure\n- Repair Atrial Septum, Open Approach\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Excision of Right Saphenous Vein, Open Approach\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Bypass Coronary Artery, One Artery from Aorta with Autologous Venous Tissue, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Supplement Mitral Valve with Synthetic Substitute, Open Approach\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Controlled ventilation procedure and therapy, initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Performance of Cardiac Output, Continuous\n\n### Condition\n- Chronic kidney disease stage 1\n- Congestive heart failure\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Atrial premature complex\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Abdominal pain\n- Low back pain\n- Rheumatic disease of mitral valve\n- Right bundle branch block\n- Acute posthemorrhagic anemia\n- Ascorbic acid deficiency\n- Combined systolic and diastolic dysfunction\n- Compression of vein\n- Gastroesophageal reflux disease without esophagitis\n- Mitral valve prolapse\n- Pneumothorax\n- Conduction disorder of the heart\n- Hypothyroidism\n- Major depression, single episode\n- Anxiety disorder\n- Atrial fibrillation\n- Chronic pain\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n- Urinary tract infectious disease\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial septal defect\n- Bifascicular block\n- Chronic atrial fibrillation\n- Chronic combined systolic and diastolic heart failure\n- Headache\n- Nausea\n- Non-rheumatic mitral valve disease\n- Paroxysmal atrial fibrillation\n- Pleural effusion\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-23\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2017-04-28\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-21\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-05-03, with intended 0 refill(s). Instructions: take 1 Aminian by mouth every 12 hours for 5 days , first dose was on 3-28 at night, last dose will be 4-3\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-04-19, presumably until 2017-04-22\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-22\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-22\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban, started on 2017-04-27, presumably until 2017-05-20, with intended 0 refill(s). Instructions: Take 1 round (15 mg) tab twice daily with food for 21 days then 1 triangle tab (20 mg) daily with food\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-27\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-04-20, presumably until 2017-04-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-28\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every morning before breakfast\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-04-20, presumably until 2017-04-25\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-04-21, presumably until 2017-04-21\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-04-20, presumably until 2017-04-24\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-23\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-04-26, presumably until 2017-04-27\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-21\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-04-20, presumably until 2017-04-21\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2017-04-20, presumably until 2017-04-27\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-20\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-04-24, presumably until 2017-04-26\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compression of vein\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2017-04-27, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-20 11:02:41, ended at 2017-05-20 12:11:36\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.22\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- rivaroxaban 20 MG Oral Tablet, through Oral route, presumably until 2020-07-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 81 mg by mouth every Monday, Wednesday and Friday\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:59:08, ended at 2018-09-26 15:02:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemorrhage of rectum and anus\n- Primary diagnosis: Nausea\n\n### Drug\n- colesevelam hydrochloride 625 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8666d13960d637ca8d9e0a450d06902e03da589b9f9a6d5672eeac0b5b040c36", "prompt_hash": "1b94bc7da0db9c3b2970003f64cfdb1faf6e14ed9a408f84d4828689f7e9794c", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 7, "doc": {"person_id": 115969703, "visit_occurrence_id": 83107325, "death_date": "2017-06-24", "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2016-02-19 09:00:00", "visit_end_datetime": "2016-02-19 23:59:00", "visit_length_in_hours": 14.983333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 922, "patient_first_visit_date": "2011-10-29 00:00:00", "patient_last_visit_date": "2017-06-18 10:23:00", "end_obs_date": "2017-02-18", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 137, "cumulated_visit_num": 137, "cumulated_approximate_token_count": 61094, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-29 00:00:00, ended at 2011-10-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-29 11:11:50, ended at 2011-10-29 12:34:54\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-26 00:00:00, ended at 2013-04-26 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-04-26, presumably until 2013-04-26, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-02, presumably until 2013-09-02, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-09 00:00:00, ended at 2013-09-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-09, presumably until 2015-06-25, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-09 09:23:43, ended at 2013-11-09 10:40:25\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Contracture of palmar fascia\n- Disorder of transplanted kidney\n- Left bundle branch hemiblock\n- Primary diagnosis: Transplanted kidney present\n- Electrocardiogram abnormal\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Inflammatory dermatosis\n- Tachycardia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2015-06-25. Instructions: inject 15 Units subcutaneous (under the skin) every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-09 10:44:00, ended at 2013-11-09 11:23:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-14 00:00:00, ended at 2013-11-14 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Kidney lesion\n- Transplanted kidney present\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-23 13:54:00, ended at 2013-11-23 21:40:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n- aPTT in Platelet poor plasma by Coagulation assay: 30.3 (second)\n- Prothrombin time (PT): 12.4 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Closed [percutaneous] [needle] biopsy of kidney\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Hydronephrosis\n- Nephrosclerosis\n- Primary diagnosis: Nephrotic syndrome\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Disorder of calcium metabolism\n- Renal function tests abnormal\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-23 14:44:14, ended at 2013-11-23 17:25:06\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-02 00:00:00, ended at 2013-12-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-14 00:00:00, ended at 2013-12-14 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired renal cystic disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-16 00:00:00, ended at 2013-12-16 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-21 00:00:00, ended at 2013-12-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-21 11:29:00, ended at 2013-12-21 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-23 13:32:00, ended at 2013-12-23 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:37:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 10:29:18, ended at 2014-01-23 11:31:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gout\n- Membranous glomerulonephritis\n- Secondary diabetes mellitus\n- Hyperlipidemia\n- Nephrotic syndrome\n- Kidney lesion\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2015-01-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. Take 1 PO every HS\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2014-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-07 14:09:59, ended at 2014-02-07 15:55:57\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-02 08:47:31, ended at 2014-03-02 09:21:27\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Left bundle branch hemiblock\n- Electrocardiogram abnormal\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-02 09:22:00, ended at 2014-03-02 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Pre-surgery evaluation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-04 09:26:00, ended at 2014-05-04 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-09, with intended 0 refill(s). Instructions: Take one cap at night. May increase to 3 capsules at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Low back pain\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-17, with intended 1 refill(s). Instructions: Take one capsule by mouth at night. Increase by one capsule, daily, up to 3 capsules, 3 times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 09:05:33, ended at 2014-05-09 10:51:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral neuritis\n- Altered sensation of skin\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-17 09:55:07, ended at 2014-05-17 11:19:08\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Contracture of palmar fascia\n- Essential hypertension\n- Transplanted kidney present\n- Gastroesophageal reflux disease\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2015-06-25. Instructions: take 300 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-19 14:58:00, ended at 2014-05-19 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Altered sensation of skin\n- Low back pain\n- Displacement of lumbar intervertebral disc without myelopathy\n- Lumbosacral spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-31 00:00:00, ended at 2014-05-31 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Acquired renal cystic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-06-02 00:00:00, ended at 2014-06-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-06-02, presumably until 2014-06-02\n- iohexol, through Intravenous route, started on 2014-06-02, presumably until 2014-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 14:19:00, ended at 2014-06-02 15:55:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Other x-ray of lumbosacral spine\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, each additional level (List separately in addition to code for primary procedure)\n- Injection of steroid\n- Injection of other agent into spinal canal\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Displacement of lumbar intervertebral disc without myelopathy\n- Gastroesophageal reflux disease\n- Transplanted kidney present\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:12, ended at 2014-06-02 15:42:38\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:13, ended at 2014-06-02 15:42:39\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, single view, specify level\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:17:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-10 00:00:00, ended at 2014-07-10 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Primary diagnosis: Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-10 15:41:35, ended at 2014-07-10 16:54:36\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Displacement of lumbar intervertebral disc without myelopathy\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-16 00:00:00, ended at 2015-03-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Urine: 12200 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 133.30 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 9152 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-06-24 23:33:00, ended at 2015-07-03 14:50:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 114 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 756 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 0.8 (microgram per milliliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid: 3.3 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 116 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 35 (percent)\n- Protein [Mass/volume] in Urine: 5857 (milligram per volume)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 83.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.22 (milligram per milligram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 269 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 23 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of kidney\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Renal biopsy; percutaneous, by trocar or needle\n- Plasmapheresis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Insertion of graft for vascular access\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Abdominal paracentesis\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n\n### Condition\n- Immune defect\n- Nephrosclerosis\n- Breathing painful\n- Disorder of transplanted kidney\n- Essential hypertension\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Nephrotic syndrome\n- Non-infectious disorder of lymphatics\n- Right lower quadrant pain\n- Acute renal papillary necrosis with renal failure\n- Disorder of calcium metabolism\n- Flatulence, eructation and gas pain\n- Nephrotic syndrome with membranous glomerulonephritis\n- Transplanted kidney present\n- Atherosclerosis of aorta\n- Disorder affecting transplanted structure\n- Disorder of plasma protein metabolism\n- Late effect of medical and surgical care complication\n- Edema\n- Hypervolemia\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cardiac arrhythmia\n- Hydronephrosis\n- Primary diagnosis: Membranous glomerulonephritis\n- Gout\n- Hyperlipidemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-06-14, presumably until 2015-08-09, with intended 11 refill(s). Instructions: take 750 mg by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-01, presumably until 2015-07-01\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-06-27, presumably until 2015-07-03\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 2.5 mg by mouth 2 times a day\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-06-25, presumably until 2015-06-27\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-06-18, presumably until 2015-08-10, with intended 2 refill(s). Instructions: take 1 mg by mouth as directed Take 1 cap (1 mg) in the morning and 2 caps (2 mg) in the evenings daily.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-03, presumably until 2015-07-12, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-08-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 3 refill(s). Instructions: take 30 mg by mouth every morning\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-06-26, presumably until 2015-06-26\n- 24 HR nifedipine 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-15, presumably until 2015-07-03, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-06-28, presumably until 2015-06-28\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-07-03, presumably until 2015-07-26, with intended 1 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 1 refill(s). Instructions: take 20 mg by mouth every morning\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-06-25, presumably until 2015-06-27\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-06-25, presumably until 2015-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-07-03\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-06-30\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-06-25, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-06-26, presumably until 2015-06-26\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-06-30, presumably until 2015-10-30, with intended 2 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2015-06-25, presumably until 2015-06-25\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-06-28, presumably until 2015-07-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-07-04, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-09-28, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-07-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-25, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-30 12:30:00, ended at 2015-06-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 355 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-01 13:00:00, ended at 2015-07-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 313 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-02 10:48:00, ended at 2015-07-02 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-04 12:53:00, ended at 2015-07-04 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 260 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-04, presumably until 2015-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-05 12:49:00, ended at 2015-07-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-05, presumably until 2015-07-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-05, presumably until 2015-07-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-05, presumably until 2015-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-06 00:00:00, ended at 2015-07-06 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 12:52:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 64.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Transplanted kidney present\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-06, presumably until 2015-07-06\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-06, presumably until 2015-07-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-07-05, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth daily Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine: 26531 (milligram per volume)\n- Creatinine [Mass/volume] in Urine: 44.4 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1255 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-09 12:55:00, ended at 2015-07-09 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 108.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-09, presumably until 2015-07-09\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-09, presumably until 2015-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-10 00:00:00, ended at 2015-07-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-10 13:00:00, ended at 2015-07-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 148 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.59 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-10, presumably until 2015-07-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-10, presumably until 2015-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-12 00:00:00, ended at 2015-07-12 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-12, presumably until 2015-07-22, with intended 3 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 11:00:00, ended at 2015-07-12 12:26:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Late effect of medical and surgical care complication\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-12 11:33:26, ended at 2015-07-12 12:22:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renovascular hypertension\n- Nephrotic syndrome\n- Primary diagnosis: Transplanted kidney present\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 12:27:00, ended at 2015-07-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 30.62 (milligram per milligram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 81.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 2483 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-07-16, presumably until 2015-07-16, with intended 2 refill(s). Instructions: take 1 Packet by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-16 10:37:00, ended at 2015-07-16 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 286 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-16, presumably until 2015-07-16\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-16, presumably until 2015-07-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-16, presumably until 2015-07-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:30:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-17, presumably until 2015-07-17\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-17, presumably until 2015-07-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-17, presumably until 2015-07-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Primary diagnosis: Kidney lesion\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-18, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-18 13:30:00, ended at 2015-07-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.50 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 204 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-18, presumably until 2015-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-18, presumably until 2015-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-08, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-24, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-20 13:00:00, ended at 2015-07-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-20, presumably until 2015-07-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-20, presumably until 2015-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-23 13:30:00, ended at 2015-07-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 101 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 271 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-24 00:00:00, ended at 2015-07-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-24, presumably until 2015-07-26, with intended 2 refill(s). Instructions: take 10 g by mouth 3 times a day X 2 days OR AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-25 13:30:00, ended at 2015-07-25 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-25, presumably until 2015-07-25\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-25, presumably until 2015-07-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: take 15 mL by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 10:02:29, ended at 2015-07-26 11:33:18\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n- Primary diagnosis: Transplanted kidney present\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Spinal stenosis of lumbar region\n- Renovascular hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 08:37:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-27, presumably until 2015-07-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-27, presumably until 2015-07-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 13:30:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 157 (milligram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-30, presumably until 2015-07-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 08:25:00, ended at 2015-08-01 08:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Creatinine [Mass/volume] in Urine: 79.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.87 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1540 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.27 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 09:00:00, ended at 2015-08-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 214 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-01, presumably until 2015-08-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-03 09:00:00, ended at 2015-08-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 320 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-03, presumably until 2015-08-03\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-03, presumably until 2015-08-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 08:47:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1189 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 66.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.99 (milligram per milligram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-06, presumably until 2015-08-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-08, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-08 08:48:00, ended at 2015-08-08 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.28 (milligram per milligram)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 153 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1639 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-08, presumably until 2015-08-08\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-08, presumably until 2015-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-09, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-03-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-09-19, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-05-14, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2017-06-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-10, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 10:25:28, ended at 2015-08-09 11:35:20\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Disorder of phosphorus metabolism\n- Tobacco dependence syndrome\n- Transplanted kidney present\n- Chronic kidney disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 15:19:02, ended at 2015-08-09 16:16:35\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily \n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-08-07, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 30 mg by mouth daily \n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-10, presumably until 2015-08-17, with intended 11 refill(s). Instructions: Take 1mg QAM and 2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-10 08:30:00, ended at 2015-08-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.23 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 112 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 166 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-10, presumably until 2015-08-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-10, presumably until 2015-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-13 08:29:00, ended at 2015-08-13 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1417 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 216 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 16.50 (milligram per milligram)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Nephrotic syndrome\n- Membranous glomerulonephritis\n- Disorder of phosphorus metabolism\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-13, presumably until 2015-08-13\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-13, presumably until 2015-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 08:23:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-15, presumably until 2015-08-15\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-15, presumably until 2015-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-17, presumably until 2015-10-06, with intended 11 refill(s). Instructions: Take 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-17 08:13:00, ended at 2015-08-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 70.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 183 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.88 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-17, presumably until 2015-08-17\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-20, presumably until 2015-08-21, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 08:22:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 974 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Body height: 5' 4.173\" (inch (US))\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 245 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.98 (milligram per milligram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-20, presumably until 2015-08-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-20, presumably until 2015-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-21, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-22 08:30:00, ended at 2015-08-22 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 962 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.63 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 55.5 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 179 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.62 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 36 (microgram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-22, presumably until 2015-08-22\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-22, presumably until 2015-08-22\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the morning Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-23 09:34:11, ended at 2015-08-23 11:50:56\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Nephrotic syndrome\n- Disorder of transplanted kidney\n- Hyperlipidemia\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Secondary thrombocytopenia\n- Primary diagnosis: Membranous glomerulonephritis\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-24 12:58:00, ended at 2015-08-24 17:51:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 312 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 243 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.35 (million per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 397 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 504 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-24, presumably until 2015-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-24 17:52:00, ended at 2015-09-04 10:24:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Urine: 36 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 9.3 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 15.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 4.15 (log international unit per milliliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 928 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 631 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 309 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 21.25 (milligram per milligram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 17.4 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 63.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 29 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 850 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3007 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 72.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Thrombin time: 18.4 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Body height: 5' 5.98\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 68.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Blood: 60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 43 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.32 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 36.2 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.80 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.60 (micro-international unit per milliliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in 24 hour Urine: 33.9 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Plasmapheresis\n- Ultrasound, abdominal, real time with image documentation; complete\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Occupational therapy evaluation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Acidosis\n- Hypervolemia\n- Lymphocytosis\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cytomegalovirus infection\n- Nephrotic syndrome with membranous glomerulonephritis\n- Ascites\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Late effect of medical and surgical care complication\n- Monoclonal gammopathy (clinical)\n- Tobacco dependence syndrome\n- Coronary arteriosclerosis\n- Pancytopenia\n- Chronic kidney disease\n- Iron deficiency anemia\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Edema\n- Hydronephrosis\n- Proteinuria\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Benign hypertensive renal disease with renal failure\n- Complication due to diabetes mellitus\n- Disorder affecting transplanted structure\n- Disorder of hematopoietic structure\n- Disorder of plasma protein metabolism\n- Hyperlipidemia\n- Postprocedural state finding\n- Anemia in chronic kidney disease\n- Disorder of kidney due to diabetes mellitus\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Renovascular hypertension\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2015-08-28, presumably until 2015-10-18, with intended 0 refill(s). Instructions: insert 1 Suppository into the rectum daily as needed\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-09-01, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed for Pain or Fever\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-28, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) 3 times a week\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-08-26, presumably until 2015-09-04\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-09-04, presumably until 2015-09-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-29\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-29, presumably until 2015-09-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-08-24, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (leg edema)\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2016-09-02, with intended 0 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-26, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 10 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-08-27, presumably until 2015-08-28, with intended 0 refill(s). Instructions: take 10 g by mouth 2 times a day\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-01, presumably until 2015-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-31\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2015-10-06, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-08-28, presumably until 2015-08-31\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-08-27, presumably until 2015-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday for 30 days\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2015-09-01, presumably until 2015-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-27 07:26:00, ended at 2015-08-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 83 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-27, presumably until 2015-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 07:53:00, ended at 2015-08-29 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 268 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-31 08:01:00, ended at 2015-08-31 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-31, presumably until 2015-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-03 08:57:00, ended at 2015-09-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 49 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-05 08:30:00, ended at 2015-09-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-05, presumably until 2015-09-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-07 08:30:00, ended at 2015-09-07 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1093 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 20.90 (milligram per milligram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 52.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-07, presumably until 2015-09-07\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-07, presumably until 2015-09-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-07, presumably until 2015-09-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-10 08:30:00, ended at 2015-09-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 202 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 213 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-10, presumably until 2015-09-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-10, presumably until 2015-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 07:30:00, ended at 2015-09-12 13:07:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 197 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Nephrotic syndrome\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Kidney lesion\n- Disorder of phosphorus metabolism\n- Membranous glomerulonephritis\n- Essential hypertension\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-12, presumably until 2015-09-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-12, presumably until 2015-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 13:08:00, ended at 2015-09-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired renal cystic disease\n- Hyperlipidemia\n- Contracture of palmar fascia\n- Kidney lesion\n- Poisoning by drug AND/OR medicinal substance\n- Tobacco dependence syndrome\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Peripheral neuritis\n- Chronic kidney disease\n- Cytomegalovirus infection\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Nephrotic syndrome\n- Secondary thrombocytopenia\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-14 09:32:00, ended at 2015-09-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-14, presumably until 2015-09-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-17 09:00:00, ended at 2015-09-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily Reduce to 10 mg daily on 10/08/2015\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 09:00:00, ended at 2015-09-19 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-19, presumably until 2015-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-20 00:00:00, ended at 2015-09-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-26 09:35:16, ended at 2015-09-26 10:39:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Type 2 diabetes mellitus without complication\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Nephrotic syndrome\n- Cytomegalovirus infection\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Renovascular hypertension\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-26 10:44:00, ended at 2015-09-26 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 144.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Neutropenia associated with infectious disease\n- Cytomegalovirus infection\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-03 09:39:30, ended at 2015-10-03 11:52:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Chronic kidney disease\n- Kidney disease\n- Hyperlipidemia\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Kidney lesion\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 13:08:00, ended at 2015-10-03 16:12:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-03, presumably until 2015-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-10-03 16:13:00, ended at 2015-10-06 13:29:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 486 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest; single view, frontal\n- Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or o\n- Hemodialysis\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n- Late effect of medical and surgical care complication\n- Pure hypercholesterolemia\n- Renovascular hypertension\n- Tobacco dependence syndrome\n- Lung field abnormal\n- Abnormal glucose level\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Leukocytosis\n- Membranous glomerulonephritis\n- Proteinuria\n- Transplanted kidney present\n- Disorder affecting transplanted structure\n- Disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Nephrotic syndrome\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Contracture of joint of hand\n- Diabetic - poor control\n- Hyperlipidemia\n- Renal failure syndrome\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-06\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-10-04, presumably until 2015-10-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-03, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed for Constipation\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-10-04, presumably until 2015-10-04\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-07-18, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-04, presumably until 2016-10-04, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-10-05, with intended 6 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every bedtime\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-06, presumably until 2015-10-06\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-17 10:41:42, ended at 2015-10-17 11:33:01\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Disorder of kidney and/or ureter\n- Renal hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Hyperlipidemia\n- Failed renal transplant\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- Nephrotic syndrome\n- Transplanted kidney present\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 11:47:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 151 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 169.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-18 12:10:29, ended at 2015-10-18 13:45:06\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Reticulocytes [#/volume] in Blood by Automated count: 130.9 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.42 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 857 (picogram per milliliter)\n- Body height: 5' 4.567\" (inch (US))\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 597.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thrombocytopenic disorder\n- Primary diagnosis: Anemia\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-10-30 12:04:00, ended at 2015-11-02 16:20:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 11.18 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 340 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 362 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1043 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 93.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, thorax, diagnostic; without contrast material\n- Performance of Urinary Filtration, Multiple (Deprecated)\n\n### Condition\n- Closed fracture of multiple ribs\n- Failed renal transplant\n- Late effect of fracture of spine AND/OR trunk without spinal cord lesion\n- Shoulder joint pain\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Gout\n- Renal hypertension\n- Chronic graft-versus-host disease\n- Late effect of complications of procedure\n- Transplanted kidney present\n- Atelectasis\n- Contracture of joint of hand\n- Pleural effusion\n- Renal disorder due to type 2 diabetes mellitus\n- Atrial premature complex\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Nephrotic syndrome\n- Nicotine dependence\n- Disorder of joint of shoulder region\n- End-stage renal disease\n- Hyperlipidemia\n- Hypertensive renal failure\n- Cerebral infarction\n- Primary diagnosis: Closed fracture of one rib\n- Disorder of kidney and/or ureter\n- Gastroesophageal reflux disease without esophagitis\n- Ventricular premature complex\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2015-10-31, presumably until 2015-10-31\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily as needed (constipation)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2017-02-21, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-01, presumably until 2015-11-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-02-27, with intended 9 refill(s). Instructions: take 10 mg by mouth 2 times a day as needed \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-31, presumably until 2015-11-02\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2015-10-30, presumably until 2015-10-30\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-30, presumably until 2015-11-01\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-31, presumably until 2015-11-02\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:19:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.77 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 707 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.1 (femtoliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.06 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 37.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-14 09:34:44, ended at 2015-11-14 10:43:05\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia of chronic disease\n- Dupuytren's disease of palm\n- Transplanted kidney present\n- End-stage renal disease\n- Nephrotic syndrome\n- Acquired renal cystic disease\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Renal disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 10:34:51, ended at 2015-11-15 11:25:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Renal disorder due to type 2 diabetes mellitus\n- Contracture of joint of hand\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2015-11-15, presumably until 2015-11-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-14 08:58:00, ended at 2015-12-14 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCV [Entitic volume] by Automated count: 78.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 13.31 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 989 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 238 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-19 09:02:32, ended at 2015-12-19 09:37:10\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Dupuytren's disease of palm\n- Renal hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Chronic kidney disease\n- Disorder of kidney and/or ureter\n- Disorder of lung\n- Failed renal transplant\n- Contracture of joint of hand\n- Hyperparathyroidism due to renal insufficiency\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- End-stage renal disease\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-31 06:59:00, ended at 2016-01-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1541 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.88 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 155.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 12:39:47, ended at 2016-01-31 15:24:19\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-14 09:30:52, ended at 2016-02-14 10:37:55\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-29 00:00:00, ended at 2011-10-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-29 11:11:50, ended at 2011-10-29 12:34:54\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-26 00:00:00, ended at 2013-04-26 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-04-26, presumably until 2013-04-26, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-02, presumably until 2013-09-02, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-09 00:00:00, ended at 2013-09-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-09, presumably until 2015-06-25, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-09 09:23:43, ended at 2013-11-09 10:40:25\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Contracture of palmar fascia\n- Disorder of transplanted kidney\n- Left bundle branch hemiblock\n- Primary diagnosis: Transplanted kidney present\n- Electrocardiogram abnormal\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Inflammatory dermatosis\n- Tachycardia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2015-06-25. Instructions: inject 15 Units subcutaneous (under the skin) every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-09 10:44:00, ended at 2013-11-09 11:23:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-14 00:00:00, ended at 2013-11-14 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Kidney lesion\n- Transplanted kidney present\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-23 13:54:00, ended at 2013-11-23 21:40:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n- aPTT in Platelet poor plasma by Coagulation assay: 30.3 (second)\n- Prothrombin time (PT): 12.4 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Closed [percutaneous] [needle] biopsy of kidney\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Hydronephrosis\n- Nephrosclerosis\n- Primary diagnosis: Nephrotic syndrome\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Disorder of calcium metabolism\n- Renal function tests abnormal\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-23 14:44:14, ended at 2013-11-23 17:25:06\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-02 00:00:00, ended at 2013-12-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-14 00:00:00, ended at 2013-12-14 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired renal cystic disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-16 00:00:00, ended at 2013-12-16 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-21 00:00:00, ended at 2013-12-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-21 11:29:00, ended at 2013-12-21 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-23 13:32:00, ended at 2013-12-23 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:37:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 10:29:18, ended at 2014-01-23 11:31:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gout\n- Membranous glomerulonephritis\n- Secondary diabetes mellitus\n- Hyperlipidemia\n- Nephrotic syndrome\n- Kidney lesion\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2015-01-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. Take 1 PO every HS\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2014-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-07 14:09:59, ended at 2014-02-07 15:55:57\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-02 08:47:31, ended at 2014-03-02 09:21:27\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Left bundle branch hemiblock\n- Electrocardiogram abnormal\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-02 09:22:00, ended at 2014-03-02 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Pre-surgery evaluation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-04 09:26:00, ended at 2014-05-04 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-09, with intended 0 refill(s). Instructions: Take one cap at night. May increase to 3 capsules at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Low back pain\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-17, with intended 1 refill(s). Instructions: Take one capsule by mouth at night. Increase by one capsule, daily, up to 3 capsules, 3 times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 09:05:33, ended at 2014-05-09 10:51:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral neuritis\n- Altered sensation of skin\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-17 09:55:07, ended at 2014-05-17 11:19:08\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Contracture of palmar fascia\n- Essential hypertension\n- Transplanted kidney present\n- Gastroesophageal reflux disease\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2015-06-25. Instructions: take 300 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-19 14:58:00, ended at 2014-05-19 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Altered sensation of skin\n- Low back pain\n- Displacement of lumbar intervertebral disc without myelopathy\n- Lumbosacral spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-31 00:00:00, ended at 2014-05-31 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Acquired renal cystic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-06-02 00:00:00, ended at 2014-06-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-06-02, presumably until 2014-06-02\n- iohexol, through Intravenous route, started on 2014-06-02, presumably until 2014-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 14:19:00, ended at 2014-06-02 15:55:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Other x-ray of lumbosacral spine\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, each additional level (List separately in addition to code for primary procedure)\n- Injection of steroid\n- Injection of other agent into spinal canal\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Displacement of lumbar intervertebral disc without myelopathy\n- Gastroesophageal reflux disease\n- Transplanted kidney present\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:12, ended at 2014-06-02 15:42:38\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:13, ended at 2014-06-02 15:42:39\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, single view, specify level\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:17:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-10 00:00:00, ended at 2014-07-10 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Primary diagnosis: Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-10 15:41:35, ended at 2014-07-10 16:54:36\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Displacement of lumbar intervertebral disc without myelopathy\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-16 00:00:00, ended at 2015-03-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Urine: 12200 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 133.30 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 9152 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-06-24 23:33:00, ended at 2015-07-03 14:50:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 114 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 756 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 0.8 (microgram per milliliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid: 3.3 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 116 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 35 (percent)\n- Protein [Mass/volume] in Urine: 5857 (milligram per volume)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 83.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.22 (milligram per milligram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 269 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 23 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of kidney\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Renal biopsy; percutaneous, by trocar or needle\n- Plasmapheresis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Insertion of graft for vascular access\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Abdominal paracentesis\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n\n### Condition\n- Immune defect\n- Nephrosclerosis\n- Breathing painful\n- Disorder of transplanted kidney\n- Essential hypertension\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Nephrotic syndrome\n- Non-infectious disorder of lymphatics\n- Right lower quadrant pain\n- Acute renal papillary necrosis with renal failure\n- Disorder of calcium metabolism\n- Flatulence, eructation and gas pain\n- Nephrotic syndrome with membranous glomerulonephritis\n- Transplanted kidney present\n- Atherosclerosis of aorta\n- Disorder affecting transplanted structure\n- Disorder of plasma protein metabolism\n- Late effect of medical and surgical care complication\n- Edema\n- Hypervolemia\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cardiac arrhythmia\n- Hydronephrosis\n- Primary diagnosis: Membranous glomerulonephritis\n- Gout\n- Hyperlipidemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-06-14, presumably until 2015-08-09, with intended 11 refill(s). Instructions: take 750 mg by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-01, presumably until 2015-07-01\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-06-27, presumably until 2015-07-03\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 2.5 mg by mouth 2 times a day\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-06-25, presumably until 2015-06-27\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-06-18, presumably until 2015-08-10, with intended 2 refill(s). Instructions: take 1 mg by mouth as directed Take 1 cap (1 mg) in the morning and 2 caps (2 mg) in the evenings daily.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-03, presumably until 2015-07-12, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-08-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 3 refill(s). Instructions: take 30 mg by mouth every morning\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-06-26, presumably until 2015-06-26\n- 24 HR nifedipine 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-15, presumably until 2015-07-03, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-06-28, presumably until 2015-06-28\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-07-03, presumably until 2015-07-26, with intended 1 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 1 refill(s). Instructions: take 20 mg by mouth every morning\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-06-25, presumably until 2015-06-27\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-06-25, presumably until 2015-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-07-03\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-06-30\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-06-25, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-06-26, presumably until 2015-06-26\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-06-30, presumably until 2015-10-30, with intended 2 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2015-06-25, presumably until 2015-06-25\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-06-28, presumably until 2015-07-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-07-04, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-09-28, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-07-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-25, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-30 12:30:00, ended at 2015-06-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 355 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-01 13:00:00, ended at 2015-07-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 313 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-02 10:48:00, ended at 2015-07-02 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-04 12:53:00, ended at 2015-07-04 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 260 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-04, presumably until 2015-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-05 12:49:00, ended at 2015-07-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-05, presumably until 2015-07-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-05, presumably until 2015-07-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-05, presumably until 2015-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-06 00:00:00, ended at 2015-07-06 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 12:52:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 64.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Transplanted kidney present\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-06, presumably until 2015-07-06\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-06, presumably until 2015-07-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-07-05, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth daily Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine: 26531 (milligram per volume)\n- Creatinine [Mass/volume] in Urine: 44.4 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1255 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-09 12:55:00, ended at 2015-07-09 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 108.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-09, presumably until 2015-07-09\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-09, presumably until 2015-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-10 00:00:00, ended at 2015-07-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-10 13:00:00, ended at 2015-07-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 148 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.59 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-10, presumably until 2015-07-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-10, presumably until 2015-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-12 00:00:00, ended at 2015-07-12 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-12, presumably until 2015-07-22, with intended 3 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 11:00:00, ended at 2015-07-12 12:26:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Late effect of medical and surgical care complication\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-12 11:33:26, ended at 2015-07-12 12:22:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renovascular hypertension\n- Nephrotic syndrome\n- Primary diagnosis: Transplanted kidney present\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 12:27:00, ended at 2015-07-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 30.62 (milligram per milligram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 81.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 2483 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-07-16, presumably until 2015-07-16, with intended 2 refill(s). Instructions: take 1 Packet by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-16 10:37:00, ended at 2015-07-16 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 286 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-16, presumably until 2015-07-16\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-16, presumably until 2015-07-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-16, presumably until 2015-07-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:30:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-17, presumably until 2015-07-17\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-17, presumably until 2015-07-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-17, presumably until 2015-07-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Primary diagnosis: Kidney lesion\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-18, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-18 13:30:00, ended at 2015-07-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.50 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 204 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-18, presumably until 2015-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-18, presumably until 2015-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-08, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-24, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-20 13:00:00, ended at 2015-07-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-20, presumably until 2015-07-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-20, presumably until 2015-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-23 13:30:00, ended at 2015-07-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 101 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 271 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-24 00:00:00, ended at 2015-07-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-24, presumably until 2015-07-26, with intended 2 refill(s). Instructions: take 10 g by mouth 3 times a day X 2 days OR AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-25 13:30:00, ended at 2015-07-25 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-25, presumably until 2015-07-25\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-25, presumably until 2015-07-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: take 15 mL by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 10:02:29, ended at 2015-07-26 11:33:18\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n- Primary diagnosis: Transplanted kidney present\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Spinal stenosis of lumbar region\n- Renovascular hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 08:37:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-27, presumably until 2015-07-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-27, presumably until 2015-07-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 13:30:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 157 (milligram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-30, presumably until 2015-07-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 08:25:00, ended at 2015-08-01 08:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Creatinine [Mass/volume] in Urine: 79.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.87 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1540 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.27 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 09:00:00, ended at 2015-08-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 214 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-01, presumably until 2015-08-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-03 09:00:00, ended at 2015-08-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 320 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-03, presumably until 2015-08-03\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-03, presumably until 2015-08-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 08:47:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1189 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 66.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.99 (milligram per milligram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-06, presumably until 2015-08-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-08, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-08 08:48:00, ended at 2015-08-08 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.28 (milligram per milligram)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 153 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1639 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-08, presumably until 2015-08-08\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-08, presumably until 2015-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-09, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-03-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-09-19, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-05-14, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2017-06-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-10, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 10:25:28, ended at 2015-08-09 11:35:20\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Disorder of phosphorus metabolism\n- Tobacco dependence syndrome\n- Transplanted kidney present\n- Chronic kidney disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 15:19:02, ended at 2015-08-09 16:16:35\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily \n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-08-07, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 30 mg by mouth daily \n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-10, presumably until 2015-08-17, with intended 11 refill(s). Instructions: Take 1mg QAM and 2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-10 08:30:00, ended at 2015-08-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.23 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 112 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 166 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-10, presumably until 2015-08-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-10, presumably until 2015-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-13 08:29:00, ended at 2015-08-13 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1417 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 216 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 16.50 (milligram per milligram)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Nephrotic syndrome\n- Membranous glomerulonephritis\n- Disorder of phosphorus metabolism\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-13, presumably until 2015-08-13\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-13, presumably until 2015-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 08:23:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-15, presumably until 2015-08-15\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-15, presumably until 2015-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-17, presumably until 2015-10-06, with intended 11 refill(s). Instructions: Take 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-17 08:13:00, ended at 2015-08-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 70.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 183 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.88 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-17, presumably until 2015-08-17\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-20, presumably until 2015-08-21, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 08:22:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 974 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Body height: 5' 4.173\" (inch (US))\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 245 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.98 (milligram per milligram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-20, presumably until 2015-08-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-20, presumably until 2015-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-21, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-22 08:30:00, ended at 2015-08-22 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 962 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.63 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 55.5 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 179 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.62 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 36 (microgram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-22, presumably until 2015-08-22\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-22, presumably until 2015-08-22\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the morning Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-23 09:34:11, ended at 2015-08-23 11:50:56\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Nephrotic syndrome\n- Disorder of transplanted kidney\n- Hyperlipidemia\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Secondary thrombocytopenia\n- Primary diagnosis: Membranous glomerulonephritis\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-24 12:58:00, ended at 2015-08-24 17:51:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 312 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 243 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.35 (million per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 397 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 504 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-24, presumably until 2015-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-24 17:52:00, ended at 2015-09-04 10:24:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Urine: 36 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 9.3 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 15.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 4.15 (log international unit per milliliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 928 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 631 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 309 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 21.25 (milligram per milligram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 17.4 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 63.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 29 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 850 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3007 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 72.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Thrombin time: 18.4 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Body height: 5' 5.98\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 68.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Blood: 60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 43 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.32 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 36.2 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.80 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.60 (micro-international unit per milliliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in 24 hour Urine: 33.9 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Plasmapheresis\n- Ultrasound, abdominal, real time with image documentation; complete\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Occupational therapy evaluation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Acidosis\n- Hypervolemia\n- Lymphocytosis\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cytomegalovirus infection\n- Nephrotic syndrome with membranous glomerulonephritis\n- Ascites\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Late effect of medical and surgical care complication\n- Monoclonal gammopathy (clinical)\n- Tobacco dependence syndrome\n- Coronary arteriosclerosis\n- Pancytopenia\n- Chronic kidney disease\n- Iron deficiency anemia\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Edema\n- Hydronephrosis\n- Proteinuria\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Benign hypertensive renal disease with renal failure\n- Complication due to diabetes mellitus\n- Disorder affecting transplanted structure\n- Disorder of hematopoietic structure\n- Disorder of plasma protein metabolism\n- Hyperlipidemia\n- Postprocedural state finding\n- Anemia in chronic kidney disease\n- Disorder of kidney due to diabetes mellitus\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Renovascular hypertension\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2015-08-28, presumably until 2015-10-18, with intended 0 refill(s). Instructions: insert 1 Suppository into the rectum daily as needed\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-09-01, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed for Pain or Fever\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-28, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) 3 times a week\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-08-26, presumably until 2015-09-04\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-09-04, presumably until 2015-09-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-29\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-29, presumably until 2015-09-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-08-24, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (leg edema)\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2016-09-02, with intended 0 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-26, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 10 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-08-27, presumably until 2015-08-28, with intended 0 refill(s). Instructions: take 10 g by mouth 2 times a day\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-01, presumably until 2015-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-31\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2015-10-06, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-08-28, presumably until 2015-08-31\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-08-27, presumably until 2015-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday for 30 days\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2015-09-01, presumably until 2015-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-27 07:26:00, ended at 2015-08-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 83 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-27, presumably until 2015-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 07:53:00, ended at 2015-08-29 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 268 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-31 08:01:00, ended at 2015-08-31 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-31, presumably until 2015-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-03 08:57:00, ended at 2015-09-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 49 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-05 08:30:00, ended at 2015-09-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-05, presumably until 2015-09-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-07 08:30:00, ended at 2015-09-07 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1093 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 20.90 (milligram per milligram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 52.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-07, presumably until 2015-09-07\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-07, presumably until 2015-09-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-07, presumably until 2015-09-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-10 08:30:00, ended at 2015-09-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 202 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 213 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-10, presumably until 2015-09-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-10, presumably until 2015-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 07:30:00, ended at 2015-09-12 13:07:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 197 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Nephrotic syndrome\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Kidney lesion\n- Disorder of phosphorus metabolism\n- Membranous glomerulonephritis\n- Essential hypertension\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-12, presumably until 2015-09-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-12, presumably until 2015-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 13:08:00, ended at 2015-09-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired renal cystic disease\n- Hyperlipidemia\n- Contracture of palmar fascia\n- Kidney lesion\n- Poisoning by drug AND/OR medicinal substance\n- Tobacco dependence syndrome\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Peripheral neuritis\n- Chronic kidney disease\n- Cytomegalovirus infection\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Nephrotic syndrome\n- Secondary thrombocytopenia\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-14 09:32:00, ended at 2015-09-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-14, presumably until 2015-09-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-17 09:00:00, ended at 2015-09-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily Reduce to 10 mg daily on 10/08/2015\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 09:00:00, ended at 2015-09-19 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-19, presumably until 2015-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-20 00:00:00, ended at 2015-09-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-26 09:35:16, ended at 2015-09-26 10:39:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Type 2 diabetes mellitus without complication\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Nephrotic syndrome\n- Cytomegalovirus infection\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Renovascular hypertension\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-26 10:44:00, ended at 2015-09-26 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 144.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Neutropenia associated with infectious disease\n- Cytomegalovirus infection\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-03 09:39:30, ended at 2015-10-03 11:52:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Chronic kidney disease\n- Kidney disease\n- Hyperlipidemia\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Kidney lesion\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 13:08:00, ended at 2015-10-03 16:12:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-03, presumably until 2015-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-10-03 16:13:00, ended at 2015-10-06 13:29:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 486 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest; single view, frontal\n- Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or o\n- Hemodialysis\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n- Late effect of medical and surgical care complication\n- Pure hypercholesterolemia\n- Renovascular hypertension\n- Tobacco dependence syndrome\n- Lung field abnormal\n- Abnormal glucose level\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Leukocytosis\n- Membranous glomerulonephritis\n- Proteinuria\n- Transplanted kidney present\n- Disorder affecting transplanted structure\n- Disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Nephrotic syndrome\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Contracture of joint of hand\n- Diabetic - poor control\n- Hyperlipidemia\n- Renal failure syndrome\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-06\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-10-04, presumably until 2015-10-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-03, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed for Constipation\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-10-04, presumably until 2015-10-04\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-07-18, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-04, presumably until 2016-10-04, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-10-05, with intended 6 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every bedtime\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-06, presumably until 2015-10-06\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-17 10:41:42, ended at 2015-10-17 11:33:01\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Disorder of kidney and/or ureter\n- Renal hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Hyperlipidemia\n- Failed renal transplant\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- Nephrotic syndrome\n- Transplanted kidney present\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 11:47:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 151 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 169.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-18 12:10:29, ended at 2015-10-18 13:45:06\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Reticulocytes [#/volume] in Blood by Automated count: 130.9 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.42 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 857 (picogram per milliliter)\n- Body height: 5' 4.567\" (inch (US))\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 597.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thrombocytopenic disorder\n- Primary diagnosis: Anemia\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-10-30 12:04:00, ended at 2015-11-02 16:20:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 11.18 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 340 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 362 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1043 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 93.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, thorax, diagnostic; without contrast material\n- Performance of Urinary Filtration, Multiple (Deprecated)\n\n### Condition\n- Closed fracture of multiple ribs\n- Failed renal transplant\n- Late effect of fracture of spine AND/OR trunk without spinal cord lesion\n- Shoulder joint pain\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Gout\n- Renal hypertension\n- Chronic graft-versus-host disease\n- Late effect of complications of procedure\n- Transplanted kidney present\n- Atelectasis\n- Contracture of joint of hand\n- Pleural effusion\n- Renal disorder due to type 2 diabetes mellitus\n- Atrial premature complex\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Nephrotic syndrome\n- Nicotine dependence\n- Disorder of joint of shoulder region\n- End-stage renal disease\n- Hyperlipidemia\n- Hypertensive renal failure\n- Cerebral infarction\n- Primary diagnosis: Closed fracture of one rib\n- Disorder of kidney and/or ureter\n- Gastroesophageal reflux disease without esophagitis\n- Ventricular premature complex\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2015-10-31, presumably until 2015-10-31\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily as needed (constipation)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2017-02-21, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-01, presumably until 2015-11-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-02-27, with intended 9 refill(s). Instructions: take 10 mg by mouth 2 times a day as needed \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-31, presumably until 2015-11-02\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2015-10-30, presumably until 2015-10-30\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-30, presumably until 2015-11-01\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-31, presumably until 2015-11-02\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:19:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.77 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 707 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.1 (femtoliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.06 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 37.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-14 09:34:44, ended at 2015-11-14 10:43:05\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia of chronic disease\n- Dupuytren's disease of palm\n- Transplanted kidney present\n- End-stage renal disease\n- Nephrotic syndrome\n- Acquired renal cystic disease\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Renal disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 10:34:51, ended at 2015-11-15 11:25:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Renal disorder due to type 2 diabetes mellitus\n- Contracture of joint of hand\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2015-11-15, presumably until 2015-11-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-14 08:58:00, ended at 2015-12-14 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCV [Entitic volume] by Automated count: 78.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 13.31 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 989 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 238 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-19 09:02:32, ended at 2015-12-19 09:37:10\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Dupuytren's disease of palm\n- Renal hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Chronic kidney disease\n- Disorder of kidney and/or ureter\n- Disorder of lung\n- Failed renal transplant\n- Contracture of joint of hand\n- Hyperparathyroidism due to renal insufficiency\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- End-stage renal disease\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-31 06:59:00, ended at 2016-01-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1541 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.88 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 155.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 12:39:47, ended at 2016-01-31 15:24:19\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-14 09:30:52, ended at 2016-02-14 10:37:55\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c8ee45243a225287597a35ea571ac01271121eb2a26ab770d2c90aa6e46db81b", "prompt_hash": "2873d28065b4d9d66645ab1c86ee40807c3aa5b8b00fe6fbdff888565f19f2a5", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 8, "doc": {"person_id": 115969886, "visit_occurrence_id": 39082554, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2010-03-19 00:00:00", "visit_end_datetime": "2010-03-19 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-19 00:00:00, ended at 2010-03-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-10-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n", "approximate_token_count": 135, "patient_first_visit_date": "2009-01-29 09:00:00", "patient_last_visit_date": "2013-12-28 00:00:00", "end_obs_date": "2011-03-19", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 71, "cumulated_visit_num": 71, "cumulated_approximate_token_count": 29932, "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2009-01-29 09:00:00, ended at 2009-01-29 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-01-30 09:40:00, ended at 2009-01-30 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-30, presumably until 2009-01-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-18 10:00:00, ended at 2009-02-18 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 450 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-19 08:40:00, ended at 2009-02-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-02-19, presumably until 2009-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-11 10:18:00, ended at 2009-03-11 11:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.37 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.26 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 354 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-03-11, presumably until 2009-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-12 09:20:00, ended at 2009-03-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-03-12, presumably until 2009-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-01 10:38:00, ended at 2009-04-01 11:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-02 09:39:00, ended at 2009-04-02 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-04-02, presumably until 2009-04-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-13 12:50:00, ended at 2009-08-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 10:17:00, ended at 2009-08-26 11:06:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.71 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.58 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 11:07:00, ended at 2009-08-26 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-02 00:00:00, ended at 2009-09-02 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 09:00:00, ended at 2009-09-02 12:36:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Reticulosarcoma\n- Anemia\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 12:37:00, ended at 2009-09-02 14:42:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Body height: 5' 10.866\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n\n### Procedure\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; separation and identification by high resolution technique (eg, capillary electrophoresis), each nucleic acid preparation\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-02 14:43:00, ended at 2009-09-04 17:05:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 10.866\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.82 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 293 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n\n### Condition\n- Acquired absence of organ\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Hyperlipidemia\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Malignant lymphoma\n- Gastroesophageal reflux disease\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed Take twice a day for 4 days after chemo and then as needed for nausea \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-04. Instructions: take 1 Tab by mouth daily. \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 125 mcg by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-09-04, presumably until 2009-10-03, with quantity of 40.0, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2010-01-14, with quantity of 0.0, with intended 0 refill(s). Instructions: take by mouth daily.\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-09-02, presumably until 2009-09-24, with intended 3 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route One Time. \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-09-04, presumably until 2009-09-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-17, with quantity of 120.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-03\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 8 mg by mouth 2 times a day. Take 2 times per day for 4 days after chemo and then as needed for nausea and vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 09:47:00, ended at 2009-09-17 11:28:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 11:29:00, ended at 2009-09-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-09-19 00:00:00, ended at 2009-09-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 07:58:00, ended at 2009-09-23 08:40:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.7 (second)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 08:41:00, ended at 2009-09-23 11:07:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 11:08:00, ended at 2009-09-23 16:25:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-23 16:26:00, ended at 2009-09-25 17:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 11.654\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n\n### Condition\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Gastroesophageal reflux disease\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Chronic pain\n- Hyperlipidemia\n- Right upper quadrant pain\n- Atrial fibrillation\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 1 Tab by mouth daily. \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-10-01, with quantity of 0.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day before meals and bedtime. For 4 days after chemo and then as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 10:00:00, ended at 2009-10-03 13:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Antineoplastic poisoning\n- Malignant lymphoma\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-03 12:17:32, ended at 2009-10-03 12:34:14\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Atrial fibrillation\n- Malignant lymphoma\n- Aneurysm of thoracic aorta\n- Congenital insufficiency of aortic valve\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-14, with quantity of 90.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-23, with quantity of 30.0, with intended 6 refill(s). Instructions: take 10 mEq by mouth Every Day. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-10-03, presumably until 2010-03-13. Instructions: take 1 Cap by mouth 2 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 14:00:00, ended at 2009-10-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 10:48:00, ended at 2009-10-22 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Malignant lymphoma\n- Hodgkin's disease (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 11:00:00, ended at 2009-10-22 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.97 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 14.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Start on 12/2 and Stop on first day of apheresis. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours. Start after chemo and continue for 4-5 days post chemo \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 28.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Start on 12/2 and Stop on first day of apheresis. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting. \n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-10-22, presumably until 2009-10-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-27 08:39:00, ended at 2009-10-27 14:55:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Removal of foreign body from skin and/or subcutaneous tissue by incision\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Ultrasonography of head and neck\n- Removal of tunneled central venous access device, with subcutaneous port or pump, central or peripheral insertion\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Venous catheterization, not elsewhere classified\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-28 08:00:00, ended at 2009-10-28 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-03 13:24:00, ended at 2009-11-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-04 10:49:00, ended at 2009-11-05 14:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 206 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 6' .441\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Congenital insufficiency of aortic valve\n- Depressive disorder\n- Gastroesophageal reflux disease\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Hyperlipidemia\n- Malignant lymphoma\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Acquired absence of organ\n- Diffuse large B-cell lymphoma (nodal/systemic with skin involvement)\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-11-05, presumably until 2009-11-05\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-11-04, presumably until 2009-11-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-04, presumably until 2009-11-04\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-11-04, presumably until 2009-11-04\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-04, presumably until 2009-11-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-11-05, presumably until 2009-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-14 07:25:00, ended at 2009-11-14 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-14, presumably until 2009-11-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-16 07:14:00, ended at 2009-11-16 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 101.0 (femtoliter)\n- Body height: 5' 11.654\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 18 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 27.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 29.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-16, presumably until 2009-11-16\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-16, presumably until 2009-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 07:30:00, ended at 2009-11-17 17:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 34.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 17:16:00, ended at 2009-11-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 07:30:00, ended at 2009-11-18 17:13:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 49.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 17:14:00, ended at 2009-11-18 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 07:30:00, ended at 2009-11-19 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 33 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 52.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 17:30:00, ended at 2009-11-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 07:30:00, ended at 2009-11-20 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 53.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.0 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 17:30:00, ended at 2009-11-20 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 07:30:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.86 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 54.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 20 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Body height: 5' 11.969\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2010-01-14. Instructions: take 500 mg by mouth as needed \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-21, presumably until 2009-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 09:08:00, ended at 2009-12-03 12:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Bone marrow transplant present\n- Disorder of gallbladder\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 13:00:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 165 (per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- CD19 cells [#/volume] in Blood: 0 (per microliter)\n- CD3 cells/100 cells in Blood: 87 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- CD19 cells/100 cells in Blood: 0 (percent)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 585 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- CD3 cells [#/volume] in Blood: 717 (per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 17:17:00, ended at 2009-12-09 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-09, presumably until 2009-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 07:21:00, ended at 2009-12-10 16:41:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 67.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 106.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 31 (percent)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 5 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 54.9 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, presumably until 2009-12-24. Instructions: 22.5 mg by SUBCUTANEOUS route as directed. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 16:42:00, ended at 2009-12-10 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-10, presumably until 2009-12-10\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-10, presumably until 2009-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-11 07:14:00, ended at 2009-12-11 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 94 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 265 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 461 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 78.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.19 (million per microliter)\n- MCV [Entitic volume] by Automated count: 106.0 (femtoliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-11, presumably until 2009-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-12 07:30:00, ended at 2009-12-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 73.9 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 51 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-12, presumably until 2009-12-12\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-12, presumably until 2009-12-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 13:53:00, ended at 2009-12-24 14:17:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 14:18:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.00 (million per microliter)\n- MCH [Entitic mass] by Automated count: 35.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- MCV [Entitic volume] by Automated count: 105.4 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.55 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-25 09:33:00, ended at 2010-01-14 14:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 125 (unit per liter)\n- MCH [Entitic mass] by Automated count: 36.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 6' .598\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.74 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.15 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 41 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Injection procedure during cardiac catheterization; for selective left ventricular or left atrial angiography\n- Autologous bone marrow transplant without purging\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Intravascular pressure measurement of coronary arteries\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Platelet transfusion\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Packed blood cell transfusion\n- Therapeutic procedure(s), group (2 or more individuals)\n- Angiocardiography of left heart\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; ventricular and/or atrial angiography\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Infusion chemotherapy for malignant neoplasm\n- Catheterization of left heart\n- Coronary arteriography using two catheters\n- Left heart catheterization, retrograde, from the brachial artery, axillary artery or femoral artery; percutaneous\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n\n### Condition\n- Lung field abnormal\n- Acute subendocardial infarction\n- Atrial fibrillation\n- Depressive disorder\n- Tachycardia\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Coronary arteriosclerosis\n- Iatrogenic hypotension\n- Osteoarthritis\n- Disorder of teeth AND/OR supporting structures\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Arthropathy\n- Gastroesophageal reflux disease\n- Hodgkin's disease, nodular sclerosis (clinical)\n- Anxiety state\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-12-28, presumably until 2010-01-01\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-03-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-31, presumably until 2010-01-14\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-12-29, presumably until 2009-12-31\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-01-03, presumably until 2010-01-03\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2009-12-30, presumably until 2010-01-13\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-12\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2011-01-14, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-29\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2009-12-25, presumably until 2010-01-13\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2009-12-29, presumably until 2010-01-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-13\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2010-01-14, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning before breakfast. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2009-12-25\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2010-01-01\n- neomycin sulfate 500 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2010-01-07, presumably until 2010-01-09\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2010-01-02\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2010-01-14, presumably until 2010-04-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 500 mg by mouth every 6 hours as needed \n- aspirin 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-28\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-27, presumably until 2010-01-05\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-02-11, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-01-02, presumably until 2010-01-14\n- 50 ML ondansetron 0.64 MG/ML Injection, through Intravenous route, started on 2009-12-26, presumably until 2009-12-31\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-12-31, presumably until 2009-12-31\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-11\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-27\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2010-01-06, presumably until 2010-01-12\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2010-01-02, presumably until 2010-01-11\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2010-01-03, presumably until 2010-01-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2010-01-01\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-25, presumably until 2010-01-02\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2010-01-07, presumably until 2010-01-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-27, presumably until 2009-12-28\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2010-01-07, presumably until 2010-01-09\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-01-10, presumably until 2010-01-10\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2010-01-01\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2009-12-27, presumably until 2010-01-13\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-01\n- vancomycin 250 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2009-12-27, presumably until 2010-01-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2010-01-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-26 09:21:21, ended at 2009-12-26 18:07:01\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n- Antineoplastic poisoning\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-15 11:22:00, ended at 2010-01-15 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 163 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-15, presumably until 2010-01-15\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 09:19:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 81 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-19, presumably until 2010-01-19\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-01-19, presumably until 2010-01-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:21:00, ended at 2010-01-23 12:22:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- MCV [Entitic volume] by Automated count: 100.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:23:00, ended at 2010-01-23 13:29:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 80 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:04:00, ended at 2010-02-04 14:21:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.16 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:22:00, ended at 2010-02-04 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 81 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 09:55:55, ended at 2010-02-11 11:46:16\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coronary atherosclerosis\n\n### Drug\n- citalopram 20 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. \n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2011-02-04, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2010-02-11. Instructions: take by mouth daily. \n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-03-13, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals. \n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-03-25. Instructions: by Sublingual route as needed \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-05-06, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 11:57:00, ended at 2010-02-11 13:06:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 13:07:00, ended at 2010-02-11 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-13 00:00:00, ended at 2010-02-13 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-02-13, presumably until 2011-02-13, with quantity of 30.0. Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:00:00, ended at 2010-02-20 11:27:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:28:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.13 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-02 10:44:00, ended at 2010-03-03 11:48:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Body height: 6' .047\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n\n### Procedure\n- Percutaneous transluminal coronary angioplasty\n- Transcatheter placement of an intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel\n- Procedure on single vessel\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Placement of stent in coronary artery\n- Insertion of one vascular stent\n\n### Condition\n- Coronary arteriosclerosis\n- Malignant lymphoma\n- Bone marrow transplant present\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:07:00, ended at 2010-03-13 13:37:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:38:00, ended at 2010-03-13 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-19 00:00:00, ended at 2010-03-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-10-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2009-01-29 09:00:00, ended at 2009-01-29 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-01-30 09:40:00, ended at 2009-01-30 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-30, presumably until 2009-01-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-18 10:00:00, ended at 2009-02-18 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 450 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-19 08:40:00, ended at 2009-02-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-02-19, presumably until 2009-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-11 10:18:00, ended at 2009-03-11 11:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.37 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.26 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 354 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-03-11, presumably until 2009-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-12 09:20:00, ended at 2009-03-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-03-12, presumably until 2009-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-01 10:38:00, ended at 2009-04-01 11:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-02 09:39:00, ended at 2009-04-02 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-04-02, presumably until 2009-04-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-13 12:50:00, ended at 2009-08-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 10:17:00, ended at 2009-08-26 11:06:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.71 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.58 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 11:07:00, ended at 2009-08-26 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-02 00:00:00, ended at 2009-09-02 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 09:00:00, ended at 2009-09-02 12:36:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Reticulosarcoma\n- Anemia\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 12:37:00, ended at 2009-09-02 14:42:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Body height: 5' 10.866\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n\n### Procedure\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; separation and identification by high resolution technique (eg, capillary electrophoresis), each nucleic acid preparation\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-02 14:43:00, ended at 2009-09-04 17:05:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 10.866\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.82 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 293 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n\n### Condition\n- Acquired absence of organ\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Hyperlipidemia\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Malignant lymphoma\n- Gastroesophageal reflux disease\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed Take twice a day for 4 days after chemo and then as needed for nausea \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-04. Instructions: take 1 Tab by mouth daily. \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 125 mcg by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-09-04, presumably until 2009-10-03, with quantity of 40.0, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2010-01-14, with quantity of 0.0, with intended 0 refill(s). Instructions: take by mouth daily.\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-09-02, presumably until 2009-09-24, with intended 3 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route One Time. \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-09-04, presumably until 2009-09-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-17, with quantity of 120.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-03\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 8 mg by mouth 2 times a day. Take 2 times per day for 4 days after chemo and then as needed for nausea and vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 09:47:00, ended at 2009-09-17 11:28:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 11:29:00, ended at 2009-09-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-09-19 00:00:00, ended at 2009-09-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 07:58:00, ended at 2009-09-23 08:40:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.7 (second)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 08:41:00, ended at 2009-09-23 11:07:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 11:08:00, ended at 2009-09-23 16:25:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-23 16:26:00, ended at 2009-09-25 17:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 11.654\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n\n### Condition\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Gastroesophageal reflux disease\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Chronic pain\n- Hyperlipidemia\n- Right upper quadrant pain\n- Atrial fibrillation\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 1 Tab by mouth daily. \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-10-01, with quantity of 0.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day before meals and bedtime. For 4 days after chemo and then as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 10:00:00, ended at 2009-10-03 13:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Antineoplastic poisoning\n- Malignant lymphoma\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-03 12:17:32, ended at 2009-10-03 12:34:14\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Atrial fibrillation\n- Malignant lymphoma\n- Aneurysm of thoracic aorta\n- Congenital insufficiency of aortic valve\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-14, with quantity of 90.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-23, with quantity of 30.0, with intended 6 refill(s). Instructions: take 10 mEq by mouth Every Day. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-10-03, presumably until 2010-03-13. Instructions: take 1 Cap by mouth 2 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 14:00:00, ended at 2009-10-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 10:48:00, ended at 2009-10-22 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Malignant lymphoma\n- Hodgkin's disease (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 11:00:00, ended at 2009-10-22 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.97 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 14.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Start on 12/2 and Stop on first day of apheresis. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours. Start after chemo and continue for 4-5 days post chemo \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 28.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Start on 12/2 and Stop on first day of apheresis. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting. \n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-10-22, presumably until 2009-10-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-27 08:39:00, ended at 2009-10-27 14:55:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Removal of foreign body from skin and/or subcutaneous tissue by incision\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Ultrasonography of head and neck\n- Removal of tunneled central venous access device, with subcutaneous port or pump, central or peripheral insertion\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Venous catheterization, not elsewhere classified\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-28 08:00:00, ended at 2009-10-28 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-03 13:24:00, ended at 2009-11-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-04 10:49:00, ended at 2009-11-05 14:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 206 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 6' .441\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Congenital insufficiency of aortic valve\n- Depressive disorder\n- Gastroesophageal reflux disease\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Hyperlipidemia\n- Malignant lymphoma\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Acquired absence of organ\n- Diffuse large B-cell lymphoma (nodal/systemic with skin involvement)\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-11-05, presumably until 2009-11-05\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-11-04, presumably until 2009-11-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-04, presumably until 2009-11-04\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-11-04, presumably until 2009-11-04\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-04, presumably until 2009-11-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-11-05, presumably until 2009-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-14 07:25:00, ended at 2009-11-14 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-14, presumably until 2009-11-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-16 07:14:00, ended at 2009-11-16 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 101.0 (femtoliter)\n- Body height: 5' 11.654\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 18 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 27.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 29.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-16, presumably until 2009-11-16\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-16, presumably until 2009-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 07:30:00, ended at 2009-11-17 17:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 34.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 17:16:00, ended at 2009-11-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 07:30:00, ended at 2009-11-18 17:13:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 49.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 17:14:00, ended at 2009-11-18 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 07:30:00, ended at 2009-11-19 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 33 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 52.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 17:30:00, ended at 2009-11-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 07:30:00, ended at 2009-11-20 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 53.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.0 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 17:30:00, ended at 2009-11-20 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 07:30:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.86 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 54.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 20 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Body height: 5' 11.969\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2010-01-14. Instructions: take 500 mg by mouth as needed \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-21, presumably until 2009-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 09:08:00, ended at 2009-12-03 12:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Bone marrow transplant present\n- Disorder of gallbladder\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 13:00:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 165 (per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- CD19 cells [#/volume] in Blood: 0 (per microliter)\n- CD3 cells/100 cells in Blood: 87 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- CD19 cells/100 cells in Blood: 0 (percent)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 585 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- CD3 cells [#/volume] in Blood: 717 (per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 17:17:00, ended at 2009-12-09 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-09, presumably until 2009-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 07:21:00, ended at 2009-12-10 16:41:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 67.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 106.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 31 (percent)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 5 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 54.9 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, presumably until 2009-12-24. Instructions: 22.5 mg by SUBCUTANEOUS route as directed. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 16:42:00, ended at 2009-12-10 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-10, presumably until 2009-12-10\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-10, presumably until 2009-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-11 07:14:00, ended at 2009-12-11 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 94 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 265 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 461 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 78.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.19 (million per microliter)\n- MCV [Entitic volume] by Automated count: 106.0 (femtoliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-11, presumably until 2009-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-12 07:30:00, ended at 2009-12-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 73.9 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 51 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-12, presumably until 2009-12-12\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-12, presumably until 2009-12-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 13:53:00, ended at 2009-12-24 14:17:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 14:18:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.00 (million per microliter)\n- MCH [Entitic mass] by Automated count: 35.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- MCV [Entitic volume] by Automated count: 105.4 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.55 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-25 09:33:00, ended at 2010-01-14 14:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 125 (unit per liter)\n- MCH [Entitic mass] by Automated count: 36.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 6' .598\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.74 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.15 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 41 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Injection procedure during cardiac catheterization; for selective left ventricular or left atrial angiography\n- Autologous bone marrow transplant without purging\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Intravascular pressure measurement of coronary arteries\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Platelet transfusion\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Packed blood cell transfusion\n- Therapeutic procedure(s), group (2 or more individuals)\n- Angiocardiography of left heart\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; ventricular and/or atrial angiography\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Infusion chemotherapy for malignant neoplasm\n- Catheterization of left heart\n- Coronary arteriography using two catheters\n- Left heart catheterization, retrograde, from the brachial artery, axillary artery or femoral artery; percutaneous\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n\n### Condition\n- Lung field abnormal\n- Acute subendocardial infarction\n- Atrial fibrillation\n- Depressive disorder\n- Tachycardia\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Coronary arteriosclerosis\n- Iatrogenic hypotension\n- Osteoarthritis\n- Disorder of teeth AND/OR supporting structures\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Arthropathy\n- Gastroesophageal reflux disease\n- Hodgkin's disease, nodular sclerosis (clinical)\n- Anxiety state\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-12-28, presumably until 2010-01-01\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-03-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-31, presumably until 2010-01-14\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-12-29, presumably until 2009-12-31\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-01-03, presumably until 2010-01-03\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2009-12-30, presumably until 2010-01-13\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-12\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2011-01-14, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-29\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2009-12-25, presumably until 2010-01-13\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2009-12-29, presumably until 2010-01-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-13\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2010-01-14, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning before breakfast. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2009-12-25\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2010-01-01\n- neomycin sulfate 500 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2010-01-07, presumably until 2010-01-09\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2010-01-02\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2010-01-14, presumably until 2010-04-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 500 mg by mouth every 6 hours as needed \n- aspirin 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-28\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-27, presumably until 2010-01-05\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-02-11, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-01-02, presumably until 2010-01-14\n- 50 ML ondansetron 0.64 MG/ML Injection, through Intravenous route, started on 2009-12-26, presumably until 2009-12-31\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-12-31, presumably until 2009-12-31\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-11\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-27\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2010-01-06, presumably until 2010-01-12\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2010-01-02, presumably until 2010-01-11\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2010-01-03, presumably until 2010-01-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2010-01-01\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-25, presumably until 2010-01-02\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2010-01-07, presumably until 2010-01-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-27, presumably until 2009-12-28\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2010-01-07, presumably until 2010-01-09\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-01-10, presumably until 2010-01-10\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2010-01-01\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2009-12-27, presumably until 2010-01-13\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-01\n- vancomycin 250 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2009-12-27, presumably until 2010-01-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2010-01-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-26 09:21:21, ended at 2009-12-26 18:07:01\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n- Antineoplastic poisoning\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-15 11:22:00, ended at 2010-01-15 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 163 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-15, presumably until 2010-01-15\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 09:19:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 81 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-19, presumably until 2010-01-19\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-01-19, presumably until 2010-01-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:21:00, ended at 2010-01-23 12:22:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- MCV [Entitic volume] by Automated count: 100.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:23:00, ended at 2010-01-23 13:29:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 80 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:04:00, ended at 2010-02-04 14:21:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.16 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:22:00, ended at 2010-02-04 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 81 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 09:55:55, ended at 2010-02-11 11:46:16\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coronary atherosclerosis\n\n### Drug\n- citalopram 20 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. \n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2011-02-04, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2010-02-11. Instructions: take by mouth daily. \n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-03-13, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals. \n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-03-25. Instructions: by Sublingual route as needed \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-05-06, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 11:57:00, ended at 2010-02-11 13:06:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 13:07:00, ended at 2010-02-11 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-13 00:00:00, ended at 2010-02-13 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-02-13, presumably until 2011-02-13, with quantity of 30.0. Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:00:00, ended at 2010-02-20 11:27:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:28:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.13 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-02 10:44:00, ended at 2010-03-03 11:48:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Body height: 6' .047\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n\n### Procedure\n- Percutaneous transluminal coronary angioplasty\n- Transcatheter placement of an intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel\n- Procedure on single vessel\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Placement of stent in coronary artery\n- Insertion of one vascular stent\n\n### Condition\n- Coronary arteriosclerosis\n- Malignant lymphoma\n- Bone marrow transplant present\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:07:00, ended at 2010-03-13 13:37:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:38:00, ended at 2010-03-13 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-19 00:00:00, ended at 2010-03-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-10-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "ea3599556b984675c618058e6ebf057e306bd08e9dd7b6a9f63f55307a9498b5", "prompt_hash": "4c47be14b4efcdd19c50e0f151e9cf7ff289f4d73208e662ae24e09b0e8b3e06", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 9, "doc": {"person_id": 115970189, "visit_occurrence_id": 56363012, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2013-09-07 12:10:53", "visit_end_datetime": "2013-09-07 13:38:58", "visit_length_in_hours": 1.4680555555555554, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2013-09-07 12:10:53, ended at 2013-09-07 13:38:58\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 112, "patient_first_visit_date": "2008-02-01 13:51:00", "patient_last_visit_date": "2023-01-29 00:00:00", "end_obs_date": "2014-09-07", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 102, "cumulated_visit_num": 102, "cumulated_approximate_token_count": 45876, "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2008-02-01 13:51:00, ended at 2008-02-01 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-15 13:45:00, ended at 2010-08-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-31 13:45:00, ended at 2010-08-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-15 11:30:00, ended at 2010-10-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-31 11:30:00, ended at 2010-10-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-12 11:30:00, ended at 2010-11-12 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-30 14:10:00, ended at 2010-11-30 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-17 08:15:00, ended at 2010-12-17 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-28 08:15:00, ended at 2010-12-28 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 08:50:00, ended at 2011-01-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-31 08:50:00, ended at 2011-01-31 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 09:00:00, ended at 2011-04-16 10:06:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 10:07:00, ended at 2011-04-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 20 ML adenosine 3 MG/ML Injection, through Intravenous route, started on 2011-04-16, presumably until 2011-04-16\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-02-27. Instructions: take 3 Tabs by mouth 3 times a day with meals. \n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth every bedtime.\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take 10 mg by mouth daily. \n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-06. Instructions: inject  subcutaneous (under the skin). 3 units before bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-26 00:00:00, ended at 2011-04-26 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-04 00:00:00, ended at 2011-07-04 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-04 15:55:44, ended at 2011-07-04 17:55:02\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-04 17:06:00, ended at 2011-07-04 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Prothrombin time (PT): 14.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 132 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-26 16:11:00, ended at 2011-11-27 13:30:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Body height: 5' 4\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.7 (percent)\n- Prothrombin time (PT): 13.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extracranial arteries; complete bilateral study\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of carotid artery\n- End-stage renal disease\n- Lung field abnormal\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- Cardiovascular symptoms\n- Transplanted kidney present\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-05 11:08:11, ended at 2011-12-05 12:13:27\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-09 08:51:00, ended at 2011-12-10 15:10:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.91 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 55 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 74 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n\n### Procedure\n- Procedure on single vessel\n- Pre-surgery evaluation\n- Endarterectomy, other vessels of head and neck\n- Hemodialysis\n\n### Condition\n- End-stage renal disease\n- Disorder of kidney due to diabetes mellitus\n- Chronic kidney disease stage 5 due to hypertension\n- Primary diagnosis: Postprocedural state finding\n- Disorder of carotid artery\n\n### Drug\n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-09. Instructions: take 20 mg by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. Patient use colace while using narcotic pain medication such as (vicodin, norco, percocet, etc) for pain control.  they may stop taking colace after no longer using that for pain control.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10. Instructions: take 10 mg by mouth daily.\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-12-10, presumably until 2011-12-10\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-09, presumably until 2011-12-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2011-12-10\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-07 00:00:00, ended at 2012-01-07 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-29 00:40:00, ended at 2012-01-29 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-30 19:27:00, ended at 2012-02-06 16:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.68 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 88 (millimeter mercury column)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 28.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Body height: 5' 3\" (inch (US))\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.5 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 420 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 47.8 (millimeter mercury column)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 99.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Other kidney transplantation\n- Delayed allogeneic transplantation, cadaver donor\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Hemodialysis\n\n### Condition\n- Acute pulmonary edema\n- Hyperkalemia\n- Late effect of medical and surgical care complication\n- Chronic kidney disease stage 5 due to hypertension\n- Ischemic heart disease\n- Retention of urine\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Disorder of kidney due to diabetes mellitus\n- Imaging of thorax abnormal\n- Lung field abnormal\n- Acute tubular necrosis\n- Disorder of carotid artery\n- Urinary tract infectious disease\n- Disorder of transplanted kidney\n- End-stage renal disease\n- Hypoxemia\n- Disorder affecting transplanted structure\n- Iatrogenic hypotension\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-02-05\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-04, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2012-02-01, presumably until 2012-02-02\n- ferrous bisglycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-04, presumably until 2012-02-06\n- ferrous aspartate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- ferrous carbonate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-02\n- ferrous glycine sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-06\n- folic acid, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-01-31, presumably until 2012-01-31\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- teferrol, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth One Time.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-05\n- ferrous asparto glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- ferrous cacodylate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-01-31, presumably until 2012-07-16, with intended 3 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-03\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2012-02-04, presumably until 2012-02-06\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-02, presumably until 2012-02-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-01, presumably until 2012-02-06\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-01-31, presumably until 2012-02-06\n- 100 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-02-01, presumably until 2012-02-04\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-06\n- iron, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. Take as directed for 1 week.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-01\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-05, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-02, presumably until 2012-02-13, with intended 0 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-07-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-04\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take as directed for 1 week.\n- methylprednisolone 125 MG Injection, started on 2012-02-01, presumably until 2012-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-31 00:00:00, ended at 2012-01-31 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-31 14:24:05, ended at 2012-01-31 14:52:56\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-08 09:41:00, ended at 2012-02-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 361 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.94 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-10 09:11:27, ended at 2012-02-10 11:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Transplanted kidney present\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-13. Instructions: take 1 Tab by mouth Every Day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-13. Instructions: inject 1-18 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 10:13:00, ended at 2012-02-10 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 17 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 361 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 360 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 08:54:12, ended at 2012-02-13 11:08:46\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 08:58:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 174 (unit per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 389 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-17 08:58:55, ended at 2012-02-17 11:07:55\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-07-16. Instructions: take 15 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-02-19. Instructions: take 5 mg by mouth 2 times a day before meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:07:00, ended at 2012-02-17 09:07:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:08:00, ended at 2012-02-17 11:12:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 11:13:00, ended at 2012-02-19 15:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: <1.5 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Body height: 5' 2.992\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 19 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n- Packed blood cell transfusion\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Splitting of blood or blood products, each unit\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; without contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Hydronephrosis\n- Pleural effusion\n- Transplanted kidney present\n- Essential hypertension\n- Imaging of abdomen abnormal\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n- Dyspnea\n- Malaise\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 3 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous bisglycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- ferrous aspartate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous carbonate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous glycine sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- folic acid, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 15 mg by mouth Every Day.\n- teferrol, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-02-18, presumably until 2012-02-19\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous asparto glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cacodylate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day before meals.\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Tabs by mouth 3 times a day with meals.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 2 times a day.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-17, presumably until 2012-02-19\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19\n- iron, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- metoprolol tartrate 100 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth 2 times a day.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2012-02-18, presumably until 2012-02-19\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-20 07:40:00, ended at 2012-02-20 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 216 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 418 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 271 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-20 08:53:50, ended at 2012-02-20 11:00:25\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-24 08:03:00, ended at 2012-02-24 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 224 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 304 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 14 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 383 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 245 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCV [Entitic volume] by Automated count: 92.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Anemia\n- Essential hypertension\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 07:35:00, ended at 2012-02-27 08:26:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 261 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 329 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 220 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 08:27:00, ended at 2012-02-27 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- Essential hypertension\n- Foreign body in genitourinary tract\n- Transplanted kidney present\n- End-stage renal disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-02-27, presumably until 2012-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-27 10:45:02, ended at 2012-02-27 14:30:30\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-02 07:44:00, ended at 2012-03-02 11:56:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.32 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 351 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 236 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-02 09:05:00, ended at 2012-03-02 10:02:24\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-03 09:20:03, ended at 2012-03-03 11:25:29\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Disease of liver\n- Infective pneumonia\n- Transplanted kidney present\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-03 11:36:00, ended at 2012-03-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Infective pneumonia\n- Lung field abnormal\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-05 09:16:00, ended at 2012-03-05 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 225 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 194 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 338 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-05 09:43:43, ended at 2012-03-05 11:00:16\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.843\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 08:33:00, ended at 2012-03-12 14:27:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 251 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 429 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-12 08:58:39, ended at 2012-03-12 10:17:33\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 14:28:00, ended at 2012-03-12 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Pulmonary emphysema\n- Lung field abnormal\n- Transplanted kidney present\n- Infective pneumonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-18 08:54:00, ended at 2012-03-18 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Hydronephrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-19 08:39:00, ended at 2012-03-19 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 211 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 396 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 206 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 236 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-19 09:02:42, ended at 2012-03-19 09:30:53\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-26 09:21:00, ended at 2012-03-26 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 12 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 248 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 79 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-26 09:50:05, ended at 2012-03-26 10:46:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.134\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 20:58:00, ended at 2012-04-05 14:33:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 165 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 17.8 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Kidney disease\n- Retention of urine\n- Anemia\n- Fever\n- Essential hypertension\n\n### Drug\n- epoetin alfa 20000 UNT/ML Injectable Solution, started on 2012-04-02, presumably until 2012-04-02\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-04-04, presumably until 2012-05-28, with intended 2 refill(s). Instructions: take 6 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-02\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-07-16. Instructions: take 5 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-05\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-04-03, presumably until 2012-04-04\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2012-04-01, presumably until 2012-04-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-03-31, presumably until 2012-04-05\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- acetylcysteine 200 MG/ML Inhalation Solution, started on 2012-04-03, presumably until 2012-04-04\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-07-02, with intended 2 refill(s). Instructions: take 2 Caps by mouth daily.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-02\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-09 09:34:50, ended at 2012-04-09 10:19:44\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-09 10:24:00, ended at 2012-04-09 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 336 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 481 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-10 00:00:00, ended at 2012-04-10 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-23 08:09:11, ended at 2012-04-23 08:19:43\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-23 09:27:00, ended at 2012-04-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 171 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 07:33:00, ended at 2012-04-30 09:42:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.9 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.89 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 175 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-30 08:10:00, ended at 2012-04-30 09:14:18\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 11:34:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-14 08:33:10, ended at 2012-05-14 09:44:32\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-14 09:50:00, ended at 2012-05-14 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 341 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 262 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-28 08:48:03, ended at 2012-05-28 09:31:57\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 09:39:00, ended at 2012-05-28 12:02:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.99 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 242 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Lung field abnormal\n- Transplanted kidney present\n- Lymphadenopathy\n- Echinococcosis of liver\n- Late effect of medical and surgical care complication\n- Disorder affecting transplanted structure\n- Imaging of abdomen abnormal\n- Essential hypertension\n- Disorder of lung\n- Hydronephrosis\n- Type 2 diabetes mellitus without complication\n- Disease of liver\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:03:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Infective pneumonia\n- Intra-abdominal and pelvic swelling, mass and lump\n- Disease of liver\n- Transplanted kidney present\n- Hydronephrosis\n- Pulmonary emphysema\n- Lung field abnormal\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-06-04 00:00:00, ended at 2012-06-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 08:27:00, ended at 2012-06-08 08:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.55 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 313 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 09:00:00, ended at 2012-06-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Lymphadenopathy\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-08 10:50:30, ended at 2012-06-08 11:23:47\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-02 08:27:52, ended at 2012-07-02 09:28:07\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, presumably until 2015-12-13. Instructions: take 0.4 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-02 09:27:00, ended at 2012-07-02 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 291 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 203 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-07-14 19:40:00, ended at 2012-07-16 13:15:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n\n### Condition\n- Hypervolemia\n- Postprocedural state finding\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Renal failure syndrome\n- Transplanted kidney present\n- Acute renal failure syndrome\n- Benign prostatic hyperplasia without outflow obstruction\n- Dyspnea\n- Pleural effusion\n- Congestive heart failure\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 10 ML furosemide 10 MG/ML Prefilled Syringe, started on 2012-07-15, presumably until 2012-07-16\n- cyclosporine, presumably until 2012-07-16. Instructions: by Misc.(Non-Drug; Combo Route) route 2 times a day.  \n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2013-01-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-07-15, presumably until 2012-07-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-07-14, presumably until 2012-07-15\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-10-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-07-15, presumably until 2012-07-16\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-07-14, presumably until 2012-07-15\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2012-07-23, with intended 1 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-07-15, presumably until 2012-07-15\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-23 09:31:00, ended at 2012-07-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 293 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.68 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-23 10:10:28, ended at 2012-07-23 11:29:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, presumably until 2012-12-04. Instructions: take 5 mg by mouth 2 times a day before meals. 10mg QAM and 5mg QPM\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2021-06-24. Instructions: take 81 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-31 07:33:00, ended at 2012-08-31 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 278 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-01 08:49:47, ended at 2012-10-01 10:18:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-01 10:22:00, ended at 2012-10-01 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 151 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 304 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-03 09:08:35, ended at 2012-12-03 10:39:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-03 10:36:00, ended at 2012-12-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 261 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-04 00:00:00, ended at 2012-12-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2014-03-11. Instructions: take 2 Tabs by mouth 2 times a day before meals.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2013-02-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-31 08:56:33, ended at 2012-12-31 10:30:02\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-31 10:33:00, ended at 2012-12-31 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 215 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.90 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 447 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 219 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 142 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-01 00:00:00, ended at 2013-01-01 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-04 09:10:56, ended at 2013-01-04 09:44:12\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-04 09:59:00, ended at 2013-01-04 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 156 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 221 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 337 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 173 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-21 08:11:00, ended at 2013-01-21 10:07:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 283 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 272 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-21 08:54:08, ended at 2013-01-21 10:02:05\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2014-03-11. Instructions: take 75 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-22 00:00:00, ended at 2013-02-22 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-22 08:44:41, ended at 2013-02-22 09:43:17\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-22 09:57:00, ended at 2013-02-22 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.67 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 125 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 10:13:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 230 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 276 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiovascular symptoms\n- Transplanted kidney present\n- Disorder of kidney due to diabetes mellitus\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 09:11:21, ended at 2013-07-26 09:45:26\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperplasia of prostate\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Cardiovascular symptoms\n- Essential hypertension\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 09:52:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 207 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.20 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-27 00:00:00, ended at 2013-07-27 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Cardiovascular symptoms\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-03 12:29:00, ended at 2013-08-03 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Cardiovascular symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-25 11:30:00, ended at 2013-08-25 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Cardiovascular symptoms\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-07 12:10:53, ended at 2013-09-07 13:38:58\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-01 13:51:00, ended at 2008-02-01 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-15 13:45:00, ended at 2010-08-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-31 13:45:00, ended at 2010-08-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-15 11:30:00, ended at 2010-10-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-31 11:30:00, ended at 2010-10-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-12 11:30:00, ended at 2010-11-12 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-30 14:10:00, ended at 2010-11-30 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-17 08:15:00, ended at 2010-12-17 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-28 08:15:00, ended at 2010-12-28 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 08:50:00, ended at 2011-01-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-31 08:50:00, ended at 2011-01-31 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 09:00:00, ended at 2011-04-16 10:06:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 10:07:00, ended at 2011-04-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 20 ML adenosine 3 MG/ML Injection, through Intravenous route, started on 2011-04-16, presumably until 2011-04-16\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-02-27. Instructions: take 3 Tabs by mouth 3 times a day with meals. \n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth every bedtime.\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take 10 mg by mouth daily. \n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-06. Instructions: inject  subcutaneous (under the skin). 3 units before bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-26 00:00:00, ended at 2011-04-26 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-04 00:00:00, ended at 2011-07-04 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-04 15:55:44, ended at 2011-07-04 17:55:02\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-04 17:06:00, ended at 2011-07-04 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Prothrombin time (PT): 14.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 132 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-26 16:11:00, ended at 2011-11-27 13:30:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Body height: 5' 4\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.7 (percent)\n- Prothrombin time (PT): 13.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extracranial arteries; complete bilateral study\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of carotid artery\n- End-stage renal disease\n- Lung field abnormal\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- Cardiovascular symptoms\n- Transplanted kidney present\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-05 11:08:11, ended at 2011-12-05 12:13:27\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-09 08:51:00, ended at 2011-12-10 15:10:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.91 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 55 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 74 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n\n### Procedure\n- Procedure on single vessel\n- Pre-surgery evaluation\n- Endarterectomy, other vessels of head and neck\n- Hemodialysis\n\n### Condition\n- End-stage renal disease\n- Disorder of kidney due to diabetes mellitus\n- Chronic kidney disease stage 5 due to hypertension\n- Primary diagnosis: Postprocedural state finding\n- Disorder of carotid artery\n\n### Drug\n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-09. Instructions: take 20 mg by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. Patient use colace while using narcotic pain medication such as (vicodin, norco, percocet, etc) for pain control.  they may stop taking colace after no longer using that for pain control.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10. Instructions: take 10 mg by mouth daily.\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-12-10, presumably until 2011-12-10\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-09, presumably until 2011-12-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2011-12-10\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-07 00:00:00, ended at 2012-01-07 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-29 00:40:00, ended at 2012-01-29 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-30 19:27:00, ended at 2012-02-06 16:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.68 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 88 (millimeter mercury column)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 28.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Body height: 5' 3\" (inch (US))\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.5 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 420 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 47.8 (millimeter mercury column)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 99.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Other kidney transplantation\n- Delayed allogeneic transplantation, cadaver donor\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Hemodialysis\n\n### Condition\n- Acute pulmonary edema\n- Hyperkalemia\n- Late effect of medical and surgical care complication\n- Chronic kidney disease stage 5 due to hypertension\n- Ischemic heart disease\n- Retention of urine\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Disorder of kidney due to diabetes mellitus\n- Imaging of thorax abnormal\n- Lung field abnormal\n- Acute tubular necrosis\n- Disorder of carotid artery\n- Urinary tract infectious disease\n- Disorder of transplanted kidney\n- End-stage renal disease\n- Hypoxemia\n- Disorder affecting transplanted structure\n- Iatrogenic hypotension\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-02-05\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-04, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2012-02-01, presumably until 2012-02-02\n- ferrous bisglycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-04, presumably until 2012-02-06\n- ferrous aspartate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- ferrous carbonate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-02\n- ferrous glycine sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-06\n- folic acid, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-01-31, presumably until 2012-01-31\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- teferrol, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth One Time.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-05\n- ferrous asparto glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- ferrous cacodylate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-01-31, presumably until 2012-07-16, with intended 3 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-03\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2012-02-04, presumably until 2012-02-06\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-02, presumably until 2012-02-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-01, presumably until 2012-02-06\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-01-31, presumably until 2012-02-06\n- 100 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-02-01, presumably until 2012-02-04\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-06\n- iron, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. Take as directed for 1 week.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-01\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-05, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-02, presumably until 2012-02-13, with intended 0 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-07-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-04\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take as directed for 1 week.\n- methylprednisolone 125 MG Injection, started on 2012-02-01, presumably until 2012-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-31 00:00:00, ended at 2012-01-31 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-31 14:24:05, ended at 2012-01-31 14:52:56\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-08 09:41:00, ended at 2012-02-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 361 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.94 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-10 09:11:27, ended at 2012-02-10 11:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Transplanted kidney present\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-13. Instructions: take 1 Tab by mouth Every Day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-13. Instructions: inject 1-18 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 10:13:00, ended at 2012-02-10 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 17 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 361 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 360 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 08:54:12, ended at 2012-02-13 11:08:46\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 08:58:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 174 (unit per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 389 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-17 08:58:55, ended at 2012-02-17 11:07:55\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-07-16. Instructions: take 15 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-02-19. Instructions: take 5 mg by mouth 2 times a day before meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:07:00, ended at 2012-02-17 09:07:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:08:00, ended at 2012-02-17 11:12:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 11:13:00, ended at 2012-02-19 15:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: <1.5 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Body height: 5' 2.992\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 19 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n- Packed blood cell transfusion\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Splitting of blood or blood products, each unit\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; without contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Hydronephrosis\n- Pleural effusion\n- Transplanted kidney present\n- Essential hypertension\n- Imaging of abdomen abnormal\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n- Dyspnea\n- Malaise\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 3 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous bisglycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- ferrous aspartate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous carbonate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous glycine sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- folic acid, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 15 mg by mouth Every Day.\n- teferrol, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-02-18, presumably until 2012-02-19\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous asparto glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cacodylate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day before meals.\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Tabs by mouth 3 times a day with meals.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 2 times a day.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-17, presumably until 2012-02-19\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19\n- iron, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- metoprolol tartrate 100 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth 2 times a day.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2012-02-18, presumably until 2012-02-19\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-20 07:40:00, ended at 2012-02-20 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 216 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 418 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 271 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-20 08:53:50, ended at 2012-02-20 11:00:25\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-24 08:03:00, ended at 2012-02-24 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 224 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 304 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 14 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 383 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 245 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCV [Entitic volume] by Automated count: 92.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Anemia\n- Essential hypertension\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 07:35:00, ended at 2012-02-27 08:26:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 261 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 329 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 220 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 08:27:00, ended at 2012-02-27 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- Essential hypertension\n- Foreign body in genitourinary tract\n- Transplanted kidney present\n- End-stage renal disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-02-27, presumably until 2012-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-27 10:45:02, ended at 2012-02-27 14:30:30\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-02 07:44:00, ended at 2012-03-02 11:56:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.32 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 351 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 236 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-02 09:05:00, ended at 2012-03-02 10:02:24\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-03 09:20:03, ended at 2012-03-03 11:25:29\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Disease of liver\n- Infective pneumonia\n- Transplanted kidney present\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-03 11:36:00, ended at 2012-03-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Infective pneumonia\n- Lung field abnormal\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-05 09:16:00, ended at 2012-03-05 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 225 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 194 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 338 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-05 09:43:43, ended at 2012-03-05 11:00:16\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.843\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 08:33:00, ended at 2012-03-12 14:27:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 251 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 429 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-12 08:58:39, ended at 2012-03-12 10:17:33\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 14:28:00, ended at 2012-03-12 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Pulmonary emphysema\n- Lung field abnormal\n- Transplanted kidney present\n- Infective pneumonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-18 08:54:00, ended at 2012-03-18 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Hydronephrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-19 08:39:00, ended at 2012-03-19 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 211 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 396 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 206 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 236 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-19 09:02:42, ended at 2012-03-19 09:30:53\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-26 09:21:00, ended at 2012-03-26 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 12 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 248 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 79 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-26 09:50:05, ended at 2012-03-26 10:46:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.134\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 20:58:00, ended at 2012-04-05 14:33:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 165 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 17.8 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Kidney disease\n- Retention of urine\n- Anemia\n- Fever\n- Essential hypertension\n\n### Drug\n- epoetin alfa 20000 UNT/ML Injectable Solution, started on 2012-04-02, presumably until 2012-04-02\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-04-04, presumably until 2012-05-28, with intended 2 refill(s). Instructions: take 6 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-02\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-07-16. Instructions: take 5 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-05\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-04-03, presumably until 2012-04-04\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2012-04-01, presumably until 2012-04-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-03-31, presumably until 2012-04-05\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- acetylcysteine 200 MG/ML Inhalation Solution, started on 2012-04-03, presumably until 2012-04-04\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-07-02, with intended 2 refill(s). Instructions: take 2 Caps by mouth daily.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-02\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-09 09:34:50, ended at 2012-04-09 10:19:44\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-09 10:24:00, ended at 2012-04-09 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 336 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 481 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-10 00:00:00, ended at 2012-04-10 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-23 08:09:11, ended at 2012-04-23 08:19:43\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-23 09:27:00, ended at 2012-04-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 171 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 07:33:00, ended at 2012-04-30 09:42:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.9 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.89 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 175 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-30 08:10:00, ended at 2012-04-30 09:14:18\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 11:34:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-14 08:33:10, ended at 2012-05-14 09:44:32\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-14 09:50:00, ended at 2012-05-14 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 341 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 262 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-28 08:48:03, ended at 2012-05-28 09:31:57\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 09:39:00, ended at 2012-05-28 12:02:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.99 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 242 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Lung field abnormal\n- Transplanted kidney present\n- Lymphadenopathy\n- Echinococcosis of liver\n- Late effect of medical and surgical care complication\n- Disorder affecting transplanted structure\n- Imaging of abdomen abnormal\n- Essential hypertension\n- Disorder of lung\n- Hydronephrosis\n- Type 2 diabetes mellitus without complication\n- Disease of liver\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:03:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Infective pneumonia\n- Intra-abdominal and pelvic swelling, mass and lump\n- Disease of liver\n- Transplanted kidney present\n- Hydronephrosis\n- Pulmonary emphysema\n- Lung field abnormal\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-06-04 00:00:00, ended at 2012-06-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 08:27:00, ended at 2012-06-08 08:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.55 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 313 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 09:00:00, ended at 2012-06-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Lymphadenopathy\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-08 10:50:30, ended at 2012-06-08 11:23:47\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-02 08:27:52, ended at 2012-07-02 09:28:07\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, presumably until 2015-12-13. Instructions: take 0.4 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-02 09:27:00, ended at 2012-07-02 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 291 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 203 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-07-14 19:40:00, ended at 2012-07-16 13:15:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n\n### Condition\n- Hypervolemia\n- Postprocedural state finding\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Renal failure syndrome\n- Transplanted kidney present\n- Acute renal failure syndrome\n- Benign prostatic hyperplasia without outflow obstruction\n- Dyspnea\n- Pleural effusion\n- Congestive heart failure\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 10 ML furosemide 10 MG/ML Prefilled Syringe, started on 2012-07-15, presumably until 2012-07-16\n- cyclosporine, presumably until 2012-07-16. Instructions: by Misc.(Non-Drug; Combo Route) route 2 times a day.  \n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2013-01-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-07-15, presumably until 2012-07-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-07-14, presumably until 2012-07-15\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-10-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-07-15, presumably until 2012-07-16\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-07-14, presumably until 2012-07-15\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2012-07-23, with intended 1 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-07-15, presumably until 2012-07-15\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-23 09:31:00, ended at 2012-07-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 293 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.68 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-23 10:10:28, ended at 2012-07-23 11:29:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, presumably until 2012-12-04. Instructions: take 5 mg by mouth 2 times a day before meals. 10mg QAM and 5mg QPM\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2021-06-24. Instructions: take 81 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-31 07:33:00, ended at 2012-08-31 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 278 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-01 08:49:47, ended at 2012-10-01 10:18:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-01 10:22:00, ended at 2012-10-01 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 151 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 304 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-03 09:08:35, ended at 2012-12-03 10:39:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-03 10:36:00, ended at 2012-12-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 261 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-04 00:00:00, ended at 2012-12-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2014-03-11. Instructions: take 2 Tabs by mouth 2 times a day before meals.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2013-02-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-31 08:56:33, ended at 2012-12-31 10:30:02\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-31 10:33:00, ended at 2012-12-31 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 215 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.90 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 447 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 219 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 142 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-01 00:00:00, ended at 2013-01-01 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-04 09:10:56, ended at 2013-01-04 09:44:12\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-04 09:59:00, ended at 2013-01-04 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 156 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 221 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 337 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 173 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-21 08:11:00, ended at 2013-01-21 10:07:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 283 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 272 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-21 08:54:08, ended at 2013-01-21 10:02:05\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2014-03-11. Instructions: take 75 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-22 00:00:00, ended at 2013-02-22 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-22 08:44:41, ended at 2013-02-22 09:43:17\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-22 09:57:00, ended at 2013-02-22 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.67 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 125 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 10:13:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 230 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 276 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiovascular symptoms\n- Transplanted kidney present\n- Disorder of kidney due to diabetes mellitus\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 09:11:21, ended at 2013-07-26 09:45:26\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperplasia of prostate\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Cardiovascular symptoms\n- Essential hypertension\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 09:52:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 207 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.20 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-27 00:00:00, ended at 2013-07-27 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Cardiovascular symptoms\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-03 12:29:00, ended at 2013-08-03 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Cardiovascular symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-25 11:30:00, ended at 2013-08-25 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Cardiovascular symptoms\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-07 12:10:53, ended at 2013-09-07 13:38:58\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Coronary arteriosclerosis within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of coronary_arteriosclerosis means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "4fa21b38b2135684c31616c520c47fac072164aab7473cf66f9766154ab86df9", "prompt_hash": "f66160047e8a43f155f532d9e87da4b67e2a7424d02c08a9fe039e77d1740958", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
